texas oncology more breakthroughs. more victories
  • Request an Appointment
  • Find a cancer center
  • Find a provider
  • Clinical Trials

Share:

 
 

Physician Publications

Date
Physicians
Publication
Title
Mittendorf E.A., Ardavanis A., Symanowski J., Murray J.L., Shumway N.M., Litton J.K., Hale D.F., Perez S.A., Anastasopoulou E.A., Pistamaltzian N.F., Ponniah S., Baxevanis C.N., von Hofe E., Papamichail M., Peoples G.E.
Annals of Oncology
Primary analysis of a prospective, randomized, single-blinded phase II trial evaluating the HER2 peptide AE37 vaccine in breast cancer patients to prevent recurrence.
Jackson, D and Perez, S and Hale, D and Greene, J and Schneble, E and Martin, J and Flores, M and Berry, J and Trappey, A and Vreeland, TJ, Hardin MO, Clifton GT, Herbert GS, Shumway, N, Papamichail M, Mittendorf EA, Peoples GE
Annals of Surgical Oncology
Correlation Between Preexisting Immunity and Clinical Response in a Phase II Trial Using HER2-Based Peptide Vaccines to Prevent Breast Cancer Recurrence
Vreeland TJ, Jackson DO, Hale DF, Greene JM, Schneble EJ, Martin J, Flores M, Berry JS, Trappey AF, Hardin MO, Clifton GT, Herbert GS, Perez S, Shumway N, Papamichail M, Peoples GE, Mittendorf EA.
Annals of Surgical Oncology
Efficacy of Booster Inoculations in a Phase II Trial of GP2, a HER2-Derived Peptide Vaccine, for the Prevention of Breast Cancer Recurrence
Hardin MO, Jackson DO, Hale DF, Greene JM, Schneble EJ, Martin J, Flores M, Berry JS, Trappey AF, Vreeland TJ, Clifton GT, Herbert GS, von Hofe E, Perez S, Shumway N, Papamichail M, Peoples GE, Mittendorf EA. 
Annals of Surgical Oncology
Impact of Boosting in the Phase II Trial of the AE37+ GM-CSF Vaccine in High-risk Breast Cancer Patients to Prevent Recurrence
Wilks, Sharon T. & Schnadig, Ian
Future Oncology
APF530 (Granisetron Inj Extended-Release) in a Three-Drug Regimen for Delayed CINV in Highly Emetogenic Chemotherapy
Agiro A, Ma Q, Acheson AK, Wu SJ, Patt DA, Baron JJ, Malin J, Schilsky RL, Lyman GH
Journal of Clinical Oncology
Risk of Neutropenia-Related Hospitalization in Patients Who Received Colony-Stimulating Factors with Chemotherapy for Breast Cancer
Patt D
Journal of Oncology Practice
Better Screening Using Big Data
Chiu L., Chow R., Popovic M., Navari R.M., Shumway N.M., Chiu N., Lam H., Milakovic M., Pasetka M., Vuong S., Chow E., DeAngelis C.
Support Care Cancer
Efficacy of olanzapine for the prophylaxis and rescue of chemotherapy-induced nausea and vomiting (CINV): a systematic review and meta-analysis.
David Lawson D, Russell M Zager, Wilkinson,J, Jackson GL, Greisinger A, Amaria RN, Stephen Lyle S, Johnson, Middlebrook BS, Oelschlager K, Cranmer L,  Windham CM, Stone J   Maetzold D, Cook R, Delman K,  Ferris L, Gerami P,  Gonzalez R
American Society of Clinical Oncology
Continued Evaluation of a 31-Gene Expression Profile test (GEP) for Prediction of distant metastases (DM) in Cutaneous Melanoma (CM)  poster presentation
Gerami P, Cook RW, Wilkinson J, Russell MC, Dhillon N, Amaria RN, Gonzalez R, Lyle S, Johnson CE, Oelschlager KM, Jackson GL, Greisinger AJ, Maetzold D, Delman KA, Lawson DH, Stone JF
Clinical Cancer Research
Development of a Prognostic Genetic Signature to Predict the Metastatic Risk Associated with Cutaneous Melanoma
Schadendorf D, Hodi FS, Robert C, Weber JS, Margolin K, Hamid O, Patt D, Chen TT, Berman DM, Wolchok JD
Journal of Clinical Oncology
Pooled Analysis of Long-Term Survival Data From Phase II and Phase III Trials of Ipilimumab in Unresectable or Metastatic Melanoma

John F. Sandbach
Gayle Patel, Elizabeth King, Brent Evans, John Kidd, Lucy Langer, Krystal L. Brown, Richard Wenstrup, Jennifer Saam

2015 ASCO Annual Meeting
A Study of Triple-Negative Breast Cancer Patients Tested With a 25-Gene Panel of Hereditary Cancer Genes.
Wilks, Sharon T., Yardley, etal.
American Society of Clinical Oncology
Weekly nab-Paclitaxel plus Gemcitabine (Gem) or Carboplatin (Carbo) versus Gem/Carbo as First Line Treatment for Metastatic Triple Negative (mTNBC) in a Phase II/III Trial (TnAcity).
Wilks, Sharon T., Slamon, et al.
American Society of Clinical Oncology
Predictive Biomarkers of Everolimus efficacy in HER2+ Advanced Breast Cancer: Combined Exploratory Analysis from BOLERO-1 and BOLERO-3.
Bersabe, Adrian REYES and Osswald, Michael B and Shumway, Nathan M
ASCO Annual Meeting Proceedings
Correlation of peripheral blood smear review and bone marrow biopsies for benign hematology Outpatient referrals.
Greene JM, Schneble EJ, Martin J, Flores M, Berry, Trappey AF, Vreeland TJ, Hale DF, Sears AK, Clifton GT, von Hofe E, Ardavannis A, Shumway N, Ponniah S, Papamichail M, Perez S, Symanowski JT, Peoples GE, Mittendorf EA.
ASCO Annual Meeting Proceedings
Final pre-specified analysis of the phase II trial of the AE37+ GM-CSF vaccine in high risk breast cancer patients to prevent recurrence.
Liang C, Li L, Fraser CD, Ko A, Corzo D, Enger C, Patt D
BMC Cancer
The treatment patterns, efficacy, and safety of nab-paclitaxel for the treatment of metastatic breast cancer in the United States: results from health insurance claims analysis
Wilks, S. & McIntyre, K
Clinical Medicine Insights: Oncology
Case Studies in the Management of Metastatic Breast Cancer with Eribulin.
Andre, Fabrice, Sara Hurvitz, Angelica Fasolo, Ling-Ming Tseng, Guy Jerusalem, Sharon Wilks, Ruth O’Regan, Claudine Isaacs, Masakazu Toi, Howard Burris, Wei He, Douglas Robinson, Markus Riester Riester, Tetiana Taran, David Chen and Dennis Salmon
Journal of Clinical Oncology
Molecular Alterations and Everolimus  Efficacy in HER2-Overexpressing Metastatic Breast Cancers: Combined Exploratory Analysis from BOLERO-1 and BOLERO-3.
Shumway, Nathan M and Dacus, Jennifer J and Lathrop, Kate I and Hernandez, Elizabeth P and Miller, Maria and Karnad, Anand B
Journal of Graduate Medical Education
Use of milestones and development of entrustable professional activities in 2 hematology/oncology training programs
Shumway, Nathan M and Terrazzino, Sandra E and Jones, Christopher B
Journal of Pain Management
A randomized pilot study comparing olanzapine (Zyprexa) to aprepitant (Emend) for treatment of chemotherapy-induced nausea and vomiting
Gerami P, Cook RW, Russell MC, Wilkinson J, Amaria RN, Gonzalez R, Lyle S, Jackson GL, Greisinger AJ, Johnson CE, Oelschlager KM, Stone JF, Maetzold DJ, Ferris LK, Wayne JD, Cooper C, Obregon R, Delman KA, Lawson D
Journal of the American Academy of Dermatology
Gene Expression Profiling for Molecular Staging of Cutaneous Melanoma in Patients undergoing Sentinel Lymph Node Biopsy
Denduluri N, Patt DA, Wang Y, Bhor M, Li X, Favret AM, Morrow PK, Barron RL, Asmar L, Saravanan S, Li Y, Garcia J, Lyman GH
Journal of the National Comprehensive Cancer Network
Dose Delays, Dose Reductions, and Relative Dose Intensity in Patients With Cancer Who Received Adjuvant or Neoadjuvant Chemotherapy in Community Oncology Practices
Yasenchak CA, Tseng WY, Yap M, Rembert D, Patt DA
Leukemia & Lymphoma
Economic impact of disease progression following front-line therapy in classical Hodgkin lymphoma
Wilks, S. et al
San Antonio Breast Cancer Symposium
Phase I study of GR antagonist Mifepristone (M) in combination with Eribulin (E)in advanced solid tumors, with dose expansion in patients (pts)with GR-positive Triple Negative Breast Cancer (TNBC).
Schnadig, Ian; Wilks, Sharon T.
San Antonio Breast Cancer Symposium
Phase 3 Comparison of APF530 versus Ondansetron, Each in a Guideline-Recommended 3-drug Regimen for Prevention of Chemotherapy Induced Nausea and Vomiting due to Anthracycline+ Cyclophosphamide (AC) Based Highly Emetogenic Chemotherapy (HEC) Regime.
O’Shaughnessy, J. et al., Wilks Sharon T.
Springer Plus Open Journal Volume 4
Impact of Prior Anthracycline or Taxane on Eribulin Effectiveness as First-Line Treatment for Metastatic Breast Cancer: Results from Two Phase 2, Multicenter, Single-arm Studies.
Wilks, Sharon T.
The Breast
Potential of Overcoming Resistance to HER2-Targeted Therapies through the PI3K/Akt/mTOR pathway.
Shumway NM, Lathrop KI, Dacus JJ, Miller M, Hernandez EP, Karnad AB
Accreditation Council of Graduate Medical Education
Use Of Milestones And Development Of Entrustable Professional Activities (EPAs) In Hematology/Oncology (HO) Training Programs -- A Proactive And Practical Approach to a New Evaluation System.
Shumway, Nathan M and Dacus, Jennifer Jill and Lathrop, Kate Ida and Hernandez, Elizabeth P and Miller, Maria and Karnad, Anand B
ASCO Annual Meeting Proceedings
Informed consent training for medical oncology fellows: Checklist-based simulation exercise.
Dacus, Jennifer Jill and Shumway, Nathan M and Lathrop, Kate Ida and Hernandez, Elizabeth P and Miller, Maria and Karnad, Anand B
ASCO Annual Meeting Proceedings
Chemotherapy infusion reaction training for medical oncology fellows: A checklist-based simulation exercise.
Mittendorf EA, Schneble EJ, Perez S, Symanowski JT, Patil R, Vreeland TJ, Berry JS, Trappey AF, Hale DF, Sears AK, Clifton GT, von Hofe E, Ardavannis A, Ponniah S, Shumway N, Papamichail M, Peoples GE. 
ASCO Annual Meeting Proceedings
Primary analysis of the prospective, randomized, phase II trial of GP2+ GM-CSF vaccine versus GM-CSF alone administered in the adjuvant setting to high-risk breast cancer patients
Erika J Schneble, Sonia A. Perez, John S. Berry, Alfred F Trappey, Tim Vreeland, Diane F. Hale, Alan K. Sears, Guy T. Clifton, Eric von Hofe, Alexandros Ardavanis, Nathan M. Shumway, Sathibalan Ponniah, Michael Papamichail, George Earl Peoples, Elizabeth Ann Mittendorf
ASCO Annual Meeting Proceedings
Comparison of recurrent and nonrecurrent breast cancer patients undergoing AE37 peptide vaccine therapy.
Elizabeth Ann Mittendorf, Erika J Schneble, Sonia A. Perez, James T Symanowski, Ritesh Patil, Timothy J. Vreeland, John S. Berry, Alfred F Trappey, Guy T. Clifton, Eric von Hofe, Alexandros Ardavanis, Sathibalan Ponniah, Nathan M. Shumway, Michael Papamichail, George Earl Peoples
ASCO Annual Meeting Proceedings
Primary analysis of the prospective, randomized, single-blinded phase II trial of AE37 vaccine versus GM-CSF alone administered in the adjuvant setting to high-risk breast cancer patients.
Bersabe, Adrian R and Osswald, Michael and Shumway, Nathan M
Blood
Peripheral Blood Smear Utilization within a Military Hematology/Oncology Fellowship Program
Wilks, Sharon et al
Clinical Breast Cancer
Phase 2, Multicenter, Single-Arm Study of Eribulin Mesylate + Trastuzumab as First Line Therapy for Locally Recurrent or Metastatic HER2 Positive Breast Cancer.

Roger M. Lyons

International Blood Research & Reviews
Iron Overload, Chelation Therapy and Survival in Lower-risk Myelodysplastic Syndromes: State of Evidence

Download full publication here.

Graham LJ, Shupe MP, Schneble EJ, Flynt FL, clemenshaw MN, Kirkpatrick AD, Gallagher C, Nissan A, Henry L, Stojadinovic A, Peoples GE, Shumway NM
Journal of Cancer
Current approaches and challenges in monitoring treatment responses in breast cancer
Schneble EJ, Graham LJ, Shupe MP, Flynt FL, Banks KP, Kirkpatrick AD, Nissan A, Henry L, Stojadinovic A, Shumway NM, Avital I, Peoples GE, Setlik RF. 
Journal of Cancer
Current approaches and challenges in early detection of breast cancer recurrence
Shupe, Matthew P and Graham, Lindsey J and Schneble, Erika J and Flynt, Frederick L and Clemenshaw, Michael N and Kirkpatrick, Aaron D and Stojadinovic, Alexander and Peoples, George E and Shumway, Nathan M
Journal of Cancer
Future directions for monitoring treatment responses in breast cancer
Schneble EJ, Graham LJ, Shupe MP, Flynt FL, Banks KP, Kirkpatrick AD, Nissan A, Henry L, Stojadinovic A, Shumway NM, Avital I, Peoples GE, Setlik RF.
Journal of Cancer
Future directions for the early detection of recurrent breast cancer
Ramakrishna N, Temin S, Chandarlapaty S, Crews JR, Davidson NE, Esteva FJ, Giordano SH, Gonzalez-Angulo AM, Kirshner JJ, Krop I, Levinson J, Modi S, Patt DA, Perez EA, Perlmutter J, Winer EP, Lin NU
Journal of Clinical Oncology
Recommendations on Disease Management for Patients With Advanced Human Epidermal Growth Factor Receptor 2-Positive Breast Cancer and Brain Metastases: American Society of Clinical Oncology Clinical Practice Guideline
Giordano SH, Temin S, Kirshner JJ, Chandarlapaty S, Crews JR, Davidson NE, Esteva FJ, Gonzalez-Angulo AM, Krop I, Levinson J, Lin NU, Modi S, Patt DA, Perez EA, Perlmutter J, Ramakrishna N, Winer EP
Journal of Clinical Oncology
Systemic Therapy for Patients With Advanced Human Epidermal Growth Factor Receptor 2-Positive Breast Cancer: American Society of Clinical Oncology Clinical Practice Guideline
Patt DA
Journal of Community and Supportive Oncology
Taking on racial and ethnic disparities in cancer care

Roger M. Lyons
Billie J. Marek, Carole Paley, Jason Esposito, Lawrence Garbo, Nicholas DiBella, Guillermo Garcia-Manero

Leukemia Research
Comparison of 24-Month Outcomes in Chelated and non-Chelated Lower-risk Patients with Myelodysplastic Syndromes in a Prospective Registry

Download full publication here.

John Sandbach
Sami Diab, Patricia Rodriguez, Anna Leininger, Lisa Clarke, Mike F. Janicek, Ellen B. Smith, Jennifer Saam, Lucy Langer

San Antonio Breast Cancer Symposium
Experience in the Community Oncology Practice with a 25-Gene Hereditary Cancer Panel
Wilks, Sharon T., Andre, Fabrice, etal
The Lancet Oncology
Everolimus for Women with Trastuzumab Resistant, HER2 Positive, Advanced Breast Cancer (BOLERO-3): A Randomized, Double Blind, Placebo Controlled Phase III Trial.
A Rojas-Martinez, AG Manzanera, SW Sukin, J Esteban-Maria, JF Gonzalez-Guerrero, L Gomez-Guerra, R Garza-Guajardo, JP Flores-Guterrez, G Elizondo Riojas, I Delgardo-Enciso, R Ortiz-Lopez, LK Aguilar, EB Butler, HA Barrera-Saldana, and E Aguilar-Cordova
Cancer Gene Therapy
Intraprostatic distribution and long-term follow-up after AdV-tk immunotherapy as neoadjuvant to surgery in patients with prostate cancer
Chen, C, Dhanda, R, Tseng, W, Forsyth, M, Patt, D
Journal of Oncology Practice
Evaluating Use Characteristics for the Oncotype DX 21-gene recurrence score and concordance with chemotherapy use in early stage breast cancer
Kaiser, A., Mohiuddin, M.M., Jackson, G.L.
Journal of Radiation Oncology
Dramatic Response from Neoadjuvant, spatially fractionated GRID radiotherapy (SFGRT) for large, high-grade extremity Sarcoma
Brow M, Hoverman JR, Patt D, Herman B, Verrilli D, Garey J, Beveridge R
Journal of the National Comprehensive Cancer Network
Defining cancer care quality or delivering quality cancer care?

Roger Lyons
Uwe Platzbecker, Raymond SM Wong, Amit Verma, Camille Abboud, Sergio Araujo, Tzeon-Jye Chiou, John Feigert, Su-Peng Yeh, Katharina Götze, Norbert-Claude Gorin, Peter Greenberg, Suman Kambhampati, Yoo-Jin Kim, Je-Hwan Lee, Marco Ruggeri, Valeria Santini, Gregory Cheng, Jun Ho Jang, Chien-Yuan Chen, Souria Dougherty, Frank Mannino, Yasser Mostafa Kamel, Geoffrey Chan, Michael Arning, Nicole Stone, Aristoteles Giagounidis

18th Congress of the European Hematology Association
Placebo-controlled, Randomized, Phase I/II Trial of the Thrombopoeitin Receptor Agonist Eltrombopag in Thrombocytopenic Patients with Advanced Myelodysplastic Syndromes or Acute Myeloid Leukemia

Download full publication here.

John F. Sandbach, MD
Joyce O’Shaughnessy, MD; David Loesch, MD; Devchand Paul, DO, PhD; Christopher T. Stokoe, MD; John E Pippen, Jr., MD; Joanne L. Blum., MD, PhD; Lea K. Krekow, MD; Frankie Ann Holmes, MD; Svetislava J. Vukelja, MD; Deborah Lindquist, MD; Scot M. Sedlacek, MD; Yunfei Wang, PhD; Stephen Jones, MD.

 

2013 ASCO Annual Meeting
ER as a Predictor of Early Breast Cancer (EBC) Outcomes in Patients ≤ 40 Years.

Roger M. Lyons, MD
Gary E Raskob, PhD, Harry Buller, MD, PhD, Pantep Angchaisuksiri, MD, Doyeun Oh, MD, PhD, Zoltan Boda, MD, PhD, DSc, Jeffrey I. Weitz, MD, George Zhang, PhD, Hans J Lanz, MD, Michele Mercuri,
MD, PhD, FAHA

55th American Society of Hematology Annual Meeting and Exposition
Edoxaban for Long-Term Treatment of Venous Thromboembolism in Cancer Patients 

Download full publication here.

Roger M. Lyons, MD
Srdan Verstovsek, MD, PhD, Ruben A. Mesa, MD, Jason Gotlib, MD, MS, Richard S. Levy, MD, Vikas Gupta, MD, FRCP, FRCPath, John F. Dipersio, MD, PhD, John V. Catalano, MD, Michael W. Deininger, MD, PhD, Carole B. Miller, MD, Richard T. Silver, Moshe Talpaz, MD, Elliott F. Winton, MD, Jimmie H. Harvey Jr., MD, Murat O. Arcasoy, MD, Elizabeth Hexner, MD, Ronald Paquette, MD, Azra Raza, MD, Kris Vaddi, PhD, William Sun, PhD, Wei Peng, PhD, Victor A. Sandor, MD, CM, Hagop M. Kantarjian, MD

55th American Society of Hematology Annual Meeting and Exposition
Long-Term Outcomes of Ruxolitinib Therapy in Patients with Myelofibrosis: 3-Year Update From COMFORT-1

Download full publication here.

Roger M. Lyons, MD
Paul J. Shaughnessy, MD, Ann Kelley, RN, Roberta Tremper, RN, Jonathan Tinker, Carlos Bachier, MD, Joseph Holahan, MD, Charles F. LeMaistre, MD

55th American Society of Hematology Annual Meeting and Exposition
The VIP (Very Immunocompromised Patient ) Protocol: Improved Access to Care and Time to Antibiotics

Download full publication here.

Roger M. Lyons
Uwe Platzbecker, MD, PhD, Raymond S.M. Wong, Amit Verma, MD, Camille N. Abboud, MD, Sergio Araujo, Tzeon-Jye Chiou, MD, John Feigert, MD, Su-Peng Yeh, MD, Katharina Götze, M.D., Norbert Claude Gorin, MD, PhD, Peter L. Greenberg, MD, Suman Kambhampati, MD, Yoo Jin Kim, MD, Je-Hwan Lee, Marco Ruggeri, MD, Valeria Santini, MD, Gregory Cheng, Jun Ho Jang, Chien-Yuan Chen, Souria Hasan Dougherty, Frank Mannino, Yasser Mostafa Kamel, Geoffrey W. Chan, MD, Nicole L. Stone, PhD, Aristoteles Giagounidis, MD

55th American Society of Hematology Annual Meeting and Exposition
Randomized, Placebo-Controlled, Phase I/II Trial of the Thrombopoietin Receptor (TPO-R) Agonist Eltrombopag in Thrombocytopenic Patients with Advanced Myelodysplastic Syndromes or Acute Myeloid Leukemia—A Subgroup Analysis of Patients Receiving Concomitant Anticancer Therapy

Download full publication here.

Roger M. Lyons, MD
Billie J. Marek, MD, Carole S. Paley, MD, Jason Esposito, MSHS, Katie McNamara, MSHS, CCRA, Lawrence Garbo, MD, Nicholas DiBella, MD, Guillermo Garcia-Manero, MD

55th American Society of Hematology Annual Meeting and Exposition
48-Month Update on Survival and AML Transformation in a 600-Patient Registry of Lower-Risk MDS Patients

Download full publication here.

Debra A. Patt, M.D. 
Clara Chen, M.S., Rahul Dhanda, Ph.D., Wan-Yu Tseng, M.S., Michael Forsyth, R.Ph., M.B.A

American Society of Clinical Oncology
Evaluating Use Characteristics for the Oncotype Dx 21-Gene Recurrence Score and Concordance With Chemotherapy Use in Early-Stage Breast Cancer

Download full publication here.

Reeder-Hayes K, Felip E, Patt D, Jaffee E
American Society of Clinical Oncology
Women in oncology
Vreeland, TJ and Berry, JS and Trappey, AF and Hale, D and Clifton, GT and Sears, A and Shumway, NM and Holmes, JP and Ponniah, S and Mittendorf, EA and others
Annals Of Surgical Oncology
Use of an Attenuated Version of a Strongly Immunogenic, Peptide-based Vaccine to Enhance an Anti-cancer Immune Response against Folate Receptor-alpha (FR alpha)
Patil, Ritesh and Clifton, Guy T and Litton, Jennifer Keating and Shumway, Nathan M and Vreeland, Timothy J and Berry, John S and Trappey, Alfred F and Ponniah, Sathibalan and Peoples, George Earl and Mittendorf, Elizabeth Ann
ASCO Annual Meeting Proceedings
Safety and efficacy of the HER2-derived GP2 peptide vaccine in combination with trastuzumab for breast cancer patients in the adjuvant setting.
Trappey, Alfred F and Berry, John S and Vreeland, Timothy J and Hale, Diane F and Sears, Alan K and Ponniah, Sathibalan and Perez, Sonia A and Clifton, Guy T and Papamichail, Michael and Shumway, Nathan M and others
ASCO Annual Meeting Proceedings
Risk factors for development of delayed urticarial reactions in the phase II trial of HER2 peptide vaccines plus GM-CSF versus GM-CSF alone in high-risk breast cancer patients to prevent recurrence.

Vivian Jean M. Cline-Burkhardt, M.D. 
J. Randolph Hecht, Allen Lee Cohn, Shaker R. Dakhil, Mansoor N. Saleh, Bilal Piperdi, Ying Tian, William Y. Go

ASCO University
SPIRITT (study 20060141): A randomized phase II study of FOLFIRI with either panitumumab (pmab) or bevacizumab (bev) as second-line treatment (tx) in patients (pts) with wild-type (WT) KRAS metastatic colorectal cancer (mCRC).

Roger M. Lyons
Srdan Verstovsek, Ruben A. Mesa, Jason Gotlib, Richard S. Levy, Vikas Gupta, John F. DiPersio, John V. Catalano, Michael Deininger, Carole Miller, Richard T. Silver, Moshe Talpaz,11 Elliott F. Winton, Jimmie H. Harvey Jr, Murat O. Arcasoy, Elizabeth Hexner, Ronald Paquette, Azra Raza, Kris Vaddi, Susan Erickson-Viitanen, William Sun, Victor Sandor, Hagop M. Kantarjian

British Journal of Haematology
The Clinical Benefit of Ruxolitinib Across Patient Subgroups: Analysis of a Placebo-controlled, Phase III Study in Patients with Myelofibrosis

Download full publication here.

Roger M Lyons
DJ Kuter, JB Bussel, A Newland, RI Baker, J Wasser, JF Viallard, G Macik, M Rummel, K Nie, S Jun.

British Journal of Haematology
Long-Term Treatment with Romiplostim in Patients with Chronic Immune Thrombocytopenia (ITP): Safety and Efficacy
Trappey, AF and Berry, JS and Vreeland, TJ and Guy, CT and Diane, HF and Alan, SK and Erika, SJ and Ferrise, L and Shumway, NM and Papamichail, M and others
Cancer Research
Abstract P4-13-05: HLA-A2 is not a prognostic indicator in breast cancer: Implications for cancer vaccine trials
Berry, John S and Trappey, Alfred F and Vreeland, Timothy J and Hale, Diane F and Clifton, Guy T and Sears, Alan K and Shumway, Nathan M and Ponniah, Sathibalan and Holmes, Jarrod P and Ioannides, Constantin and others
Cancer Research
Use of an attenuated version of a strongly immunogenic, peptide-based vaccine to enhance an anti-cancer immune response against folate receptor-alpha.
Vreeland, TJ and John, BS and Trappey, AF and Schneble, EJ and Hale, DF and Clifton, GT and Shumway, NM and Perez, SA and Papamichail, M and Ponniah, S and others
Cancer Research
Breast cancer patients with HER2 low-expression: An under-recognized group at significant risk for recurrence
Berry, JS and Trappey, AF and Vreeland, TJ and Schneble, EJ and Clifton, GT and Hale, DF and Sears, AK and Ponniah, S and Shumway, NM and Mittendorf, EA and others
Cancer Research
Preliminary results for the phase 1 trial of a dual HER2 peptide cancer vaccine in breast and ovarian cancer patients

Roger M. Lyons
Deirdra R. Terrell, PhD, James N. George, MD, James B. Bussel, MD, MD, FACP, Vinod Pullarkat, MD, Robert L. Redner, MD, Dominik Selleslag, MD, Kun Nie, PhD, Paul Woodard, MD

Community Oncology
Self-Administration of Romiplostim in Patients with Chronic Immune Thrombocytopenia (ITP)

Download full publication here.

Roger M. Lyons
Andres Siulnik, Vikas Gupta, Mahmudul Khan, John F. DiPersio, Mari McQuitty, John V. Catalano, Deborah S. Hunter, Laurent Knoops, Michael Deininger, Francisco Cervantes, Carole Miller, Alessandro M. Vannucchi, Richard T. Silver, Tiziano Barbui, Moshe Talpaz, Giovanni Barosi, Elliott F. Winton, Estella Mendeson, Jimmie H. Harvey, Jr, Murat O. Arcasoy, Elizabeth Hexner, Richard Levy, Ronald Paquette, Azra Raza, William Sun, Victor Sandor, Hagop M. Kantarjian, Claire Harrison

Haematologica
Comparison of Placebo and Best Available Therapy for the Treatment of Myelofibrosis in the Phase 3 COMFORT Studies

Download full publication here.

Roger M. Lyons
Richard S. Levy, Srdan Verstovsek, Ruben A. Mesa, Jason Gotlib, Vikas Gupta, John F. DiPersio, John V. Catalano, Michael W.N. Deininger, Carole B. Miller, Richard T. Silver, Moshe Talpaz, Elliott F. Winton, Jimmie H. Harvey, Murat O. Arcasoy, Elizabeth O. Hexner, Roger M. Lyons, Ronald Paquette, Azra Raza, Kris Vaddi, Susan Erickson-Viitanen, William Sun, Victor Sandor, and Hagop M. Kantarjian

Haematologica
Efficacy, Safety and Survival with Ruxolitinib Treatment in Patients with Myelofibrosis: Results of a Median 2-year Follow-up of COMFORT-1

Download full publication here.

Schneble, Erika J and Berry, John S and Trappey, Alfred F and Vreeland, Timothy J and Hale, Diane F and Sears, Alan K and Clifton, Guy T and Ponniah, Sathibalan and Shumway, Nathan M and Mittendorf, Elizabeth A and others
Journal for Immunotherapy of Cancer
Vaccine-specific T-cell proliferation in response to a dual peptide cancer vaccine in breast and ovarian cancer patients.

Roger M Lyons
Billie J. Marek, Carole S. Paley, Jason Esposito, Lawrence E. Garbo, Nicholas J. DiBella, Guillermo Garcia-Manero

Journal of Clinical Oncology
A 36-Month Analysis of Treatment Patterns of Outcomes in Patients with Lower-Risk Myelodysplastic Syndromes from a Prospective Observational Study

Download full publication here.

Roger M Lyons
Moshe Talpaz, Ronald Paquette, Lawrence Afrin, Solomon I Hamburg, Josef T Prchal, Katarzyna Jamieson, Howard R Terebelo, Gregory L Ortega, Ramon V Tiu, Elliott F Winton11, Kavita Natrajan, Olatoyosi Odenike, David Claxton, Wei Peng, Peter O’Neill, Susan Erickson-Viitanen, Lance Leopold, Victor Sandor, Richard S Levy, Hagop M Kantarjian, Srdan Verstovsek

Journal of Hematology & Oncology
Interim Analysis of Safety and Efficacy of Ruxolitinib in Patients with Myelofibrosis and Low Platelet Count

Download full publication here.

Roger M. Lyons
Moshe Talpaz, Ronald Paquette, Lawrence Afrin, Solomon I Hamburg, Josef T Prchal, Katarzyna Jamieson, Howard R Terebelo, Gregory L Ortega, Ramon V Tiu, Elliott F Winton, Kavita Natrajan, Olatoyosi Odenike, David Claxton, Wei Peng, Peter O’Neill, Susan Erickson-Viitanen, Lance Leopold, Victor Sandor, Richard S Levy, Hagop M Kantarjian, Srdan Verstovsek

Journal of Hematology & Oncology
Interim Analysis of Safety and Efficacy of Ruxolitinib in Patients with Myelofibrosis and Low Platelet Counts

Download full publication here.

Ramsey SD, Sullivan SD, Reed SD, Tina Shih YC, Schaecher K, Dhanda R, Patt D, Pendergrass K, Walker M, Malin J, Schwartzberg L, Neumann K, Yu E, Ravelo A, Small A. 
Oncologist
Oncology comparative effectiveness research: a multistakeholder perspective on principles for conduct and reporting

Vivian J.M. Cline-Burkhardt 
Tyvin A Rich,Kathryn Winter,Howard Safran,John P. Hoffman,Beth Erickson,Pramila R. Anne,Robert J. Myerson,Kimberly Perez,Christopher Willett

OncoTargets and Therapy
Paclitaxel, gemcitabine, irradiation, and R115777 for pancreas cancer

Download full publication here.

Wilks, Sharon, et al.
San Antonio Breast Cancer Symposium
Phase 2, Multicenter, Single-Arm Study of Eribulin Mesylate + Trastuzumab as First Line Therapy for Locally Recurrent or Metastatic HER2 Positive Breast Cancer.

Joyce O’Shaughnessy, MD
Linda Vahdat, MD, Lee Schwartzberg, MD, Sharon Wilks, MD, FACP, Jessicca Rege, PhD, Wenquan Wang, PhD, David Cox, PhD

35th Annual San Antonio Breast Cancer Symposium
Eribulin Mesylate with Trastuzumab as First-Line Therapy for Locally Recurrent or Metastatic Human Epidermal Growth Factor Receptor Two (HER2)-Positive Breast Cancer: Preliminary Results from a Phase 2, Multicenter, Single-Arm Study

Download full publication here.

Roger M. Lyons, MD
Srdan Verstovsek, MD, PhD, Ruben A. Mesa, Jason Gotlib, Richard S. Levy, MD, Vikas Gupta, MD, FRCP, FRCPath, John F. DiPersio, MD, PhD, John V. Catalano, MD, Michael W.N. Deininger, MD, PhD, Carole B. Miller, MD, Richard T. Silver, MD, Moshe Talpaz, MD, Elliott F. Winton, MD, Jimmie H. Harvey, Jr., MD, Murat O. Arcasoy, MD, Elizabeth O. Hexner, MD, Ronald Paquette, MD, PhD, Azra Raza, MD, Kris Vaddi, PhD, Susan Erickson-Viitanen, PhD, William Sun, PhD, Victor A. Sandor, MD, CM, Hagop M. Kantarjian, MD

54th Annual Meeting of the American Society of Hematology
Long-Term Outcome of Ruxolitinib Treatment in Patients with Myelofibrosis: Durable Reductions in Spleen Volume, Improvements in Quality of Life, and Overall Survival Advantage in COMFORT-1

Download full publication here.

Roger M Lyons, MD
Billie J. Marek, MD, Carole Paley, MD, Jason Esposito, MSHS, Lawrence Garbo, MD, Nicholas DiBella, MD, Guillermo Garcia-Manero, MD

54th Annual Meeting of the American Society of Hematology
Relationship Between Chelation and Clinical Outcomes in 600 Lower-Risk MDS Patients: Registry Analysis At 36 Months

Download full publication here.

Roger M Lyons, MD
Sharon T. Wilks, MD, David J. Friedman, MD, PhD, Shelby A Young, RN, BSN, Gail Brown, MD

54th Annual Meeting of the American Society of Hematology
Oral Ezatiostat HCL (Telintra), a Glutathione Analog Prodrug GSTP-1Inhibitor, for Treatment of Patients with Myeloid Growth Factor-Resistant Idiopathic Chronic Neutropenia

Download full publication here.

Roger M. Lyons, MD
Douglas B. Cines, MD, Terry B. Gernsheimer, MD, Jeffrey Wasser, MD, Bertrand Godeau, MD, Andrew Provan, MD, Ivy Altomare, Xuena Wang, PhD, Paul Woodard, MD

54th Annual Meeting of the American Society of Hematology
Integrated Analysis of Long-Term Safety in Patients with Chronic Immune Thrombocytopenia Treated with Romiplostim

Download full publication here.

Roger M. Lyons
Moshe Talpaz, Ronald Paquette, Lawrence Afrin, Solomon Hamburg, Katarzyna Jamieson, Howard Terebelo, Gregory Ortega, Ramon V. Tiu, Elliott F. Winton, Kavita Natrajan, Olatoyosi Odenike, Wei Peng, Victor A. Sandor, Peter O'Neill, Sue Erickson-Viitanen, Lance Leopold, Richard S Levy, Hagop M Kantarjian, Srdan Verstovsek

54th Annual Meeting of the American Society of Hematology
Efficacy, Hematologic Effects, and Dose of Ruxolitinib in Myelofibrosis Patients with Low Starting Platelet Counts (50-100 x 10^9/L): A Comparison to Patients with Normal or High Starting Platelet Counts

Download full publication here.

Hale DF, Vreeland TJ, Dabney RS, Clifton GT, Sears AK, Pappou E, Anastosopoulou E, Ardavanis A, Ponniah S, Papamichail M, Perez S, Shumway N, Peoples GE, Mittendorf E.
American Association for Cancer Research AACR
Abstract LB-218: Immune response assessment in a phase II trial of AE37 HER2 peptide vaccine

Roger M Lyons

American Journal of Medicine
Myelodysplastic Syndromes: Therapy and Outlook

Download full publication here.

Shumway, Nathan M and Struble, Erika J
ASCO Annual Meeting Proceedings
Prospective survey study regarding the implementation of new communication skills curriculum for medical oncology trainees.
Diane F Hale, Sonia A. Perez, Timothy J Vreeland, Alfred F Trappey, Raetasha Sheavette Dabney, John S. Berry, Alexandros Ardavanis, Alan K. Sears, Michael Papamichail, Guy T. Clifton, Efi Pappou, Ritesh Patil, Eleftheria Anastasopoulou, Sathibalan Ponniah, Nathan M. Shumway, George Earl Peoples and Elizabeth Ann Mittendorf 
ASCO Annual Meeting Proceedings
An assessment of disease features and immune response in breast cancer patients that did not recur after receiving HER2 peptide, AE37 vaccine in a randomized phase II trial.
Mittendorf, Elizabeth Ann and Perez, Sonia A and Hale, Diane F and Vreeland, Timothy J and Sears, Alan K and Clifton, Guy T and Ardavanis, Alexandros and Shumway, Nathan M and Murray, James L and Ponniah, Sathibalan and others
ASCO Annual Meeting Proceedings
Early efficacy analysis of the AE37 vaccine in patients with HER2 low-expressing and triple-negative breast cancer.
Dabney, Raetasha Sheavette and Hale, Diane F and Vreeland, Timothy J and Clifton, Guy T and Sears, Alan K and Patil, Ritesh and Ponniah, Sathibalan and Shumway, Nathan M and Peoples, George Earl and Mittendorf, Elizabeth Ann
ASCO Annual Meeting Proceedings
Safety and long-term maintenance of anti-HER2 immunity following booster inoculations of the E75 breast cancer vaccine.
Vreeland TJ, Hale DF, Sears AK, Clifton GT, Pappou E, Dabney RS, Ardavanis A, Patil R, Ponniah S, Anastasopoulou E, Perez SA, Papamichail M, Shumway NM, Peoples GE, Mittendorf EA.
ASCO Annual Meeting Proceedings
From bench to bedside: The use of the li-Key technology to improve helper peptides for clinical use in cancer vaccines.
Hale, DF and Vreeland, TJ and Perez, SA and Berry, JS and Ardavanis, A and Trappey, AF and Tzonis, P and Sears, AK and Clifton, GT and Shumway, NM and others
Cancer Research
The combination of trastuzumab and HER2-directed peptide vaccines is safe in HER2-expressing breast cancer patients
Vreeland, Timothy J and Dabney, Raetasha S and Hale, Diane F and Sears, Alan K and Clifton, Guy T and Zacharia, Athina and Jama, Yusuf and Chiplis, Anna and Mursal, Mohamed and Shumway, Nathan M and others
Cancer Research
Immune reconstitution after chemotherapy correlates with increased in vitro immune response in breast cancer patients undergoing peptide vaccine therapy
Diane F. Hale, Timothy J. Vreeland, Raetasha S. Dabney, G Travis Clifton, Alan K. Sears, Efi Pappou, Eleftheria Anastasopoulou, Alexandros Ardavanis, Sathibalan Ponniah, Michael Papamichail, Sonia Perez, Nathan Shumway, George E. Peoples, Elizabeth Mittendorf
Cancer Research
Abstract LB-218: Immune response assessment in a phase II trial of AE37 HER2 peptide vaccine
JM Greene, EJ Schneble, S Perez, JL Murray, JS Berry, AF Trappey, DF Hale, TJ Vreeland, GT Clifton, A Ardavanis, JK Litton, NM Shumway, M Papamichail, GE Peoples, EA Mittendorf 
Cancer Research
Abstract P2-11-01: Final pre-specified analysis of the phase II trial of the GP2+ GM-CSF peptide vaccine in high risk breast cancer patients to prevent recurrence

Weinthal, Joel, M.D

Clinical Roundtable Monograph
Disease State Awareness in Gaucher Disease: A Q&A Expert Roundtable Discussion
Brow M, Okon T, George E, Eagle D, Patt D, Gould B, Brooks B, Cobb P, White C, Tetrault S, Beveridge R.
Community Oncology
Thoughts and recommendations on cancer care site of service

John Sandbach, M.D. 
Lucy Langer, M.D., M.S.H.S., Lisa Clark, F.N.P., A.O.C.N.P., Justin Gress, Debra Patt, M.D., Neelima Denduluri, M.D., Yunfei Wang, Ph.D., Jay Andersen, M.D., Magdolna Solti, M.D., Amanda Wheeler, M.D., Tammy Delamelena, M.D., John Smith II, M.D.

Compass Oncology
A Structured Genetic Risk Evaluation and Testing Program in the Community Oncology Practice Increases Identification of Individuals at Risk for BRCA Mutations

Download full publication here.

R Lyons
S Verstovsek, R Mesa, J Gotlib, R Levy, V Gupta, J DiPersio, J Catalano, M Deininger, C Miller, R Silver, M Talpaz, E Winton, J Harvey, M Arcasoy, E Hexner, R Paquette, A Raza, K Vaddi, S Erickson-Viitanen, W Sun, V Sandor, H Kantarjian

European Focus on Myeloproliferative Neoplasms and Myelodysplastic Syndromes
Consistent Benefit of Ruxolitinib Over Placebo Across Myelofibrosis Patient Subgroups: Results From COMFORT-1

Download full publication here.

Hale, Diane F and Clifton, G Travis and Sears, Alan K and Vreeland, Timothy J and Shumway, Nathan and Peoples, George E and Mittendorf, Elizabeth A
Expert Review of Vaccines
Cancer vaccines: should we be targeting patients with less aggressive disease?

John F. Sandbach, M.D. 
Anne-Renee Hartman, M.D., Rajesh R. Kaldate, M.S., Lisa M. Sailer, M.S.N., Lisa Painter, M.S.N., Charles E. Grier, Ph.D., Robbin R. Endsley, M.S., Marlena Griffin, B.S., Stephanie A. Hamilton, B.A., Cynthia A. Frye, M.S., Mark A. Silberman, M.D. and Richard J.Wenstrup, M.D.

Hartman
Prevalence of BRCA Mutations in an Unselected Population of Triple-Negative Breast Cancer

Download full publication here.

Patt D, Espirito J, Turnwald B, Hoverman J, Neubauer M, Cartwright T, Busby L, Brooks B, Sitarik M, Kolodiej M, Beveridge R
JCO supplements
Changes in adjuvant breast cancer chemotherapy regimen selection over time in the community

Roger M. Lyons
Moshe Talpaz, Solomon I. Hamburg, Katarzyna Jamieson, Howard R. Terebelo, Lawrence Afrin, Elliott F. Winton, Michael A. Scola, Jimmie Huling Harvey, Chris E. Holmes, Gregory L. Ortega, Josef T. Prchal, Richard T. Silver, Maria R. Baer, Susan Kay Erickson-Viitanen, Peter O'Neill, Wei Peng, Lance Leopold, Hagop Kantarjian, Srdan Verstovsek

Journal of Clinical Oncology
Preliminary Safety and Efficacy of Ruxolitinib in Patients with Primary and Secondary Myelofibrosis with Platelet Counts of 50-100x10^9L

Download full publication here.

Roger M. Lyons
Srdan Verstovsek, Ruben A. Mesa, Jason R. Gotlib, Vikas Gupta, John F. DiPersio, John V. Catalano, Michael W.N. Deininger, Carole Brennan Miller, Richard T. Silver, Moshe Talpaz, Elliott F. Winton, Jimmie Huling Harvey, Murat O. Arcasoy, Elizabeth O. Hexner,Ronald Paquette, Azra Raza, William Sun, Hagop Kantarjian

Journal of Clinical Oncology
Adverse Events and the Return of Myelofibrosis-Related Symptoms After Treatment Interruption or Discontinuation in the Comfort-I Study

Download full publication here.

Roger M. Lyons
Eunice S Wang, Roger M Lyons, Richard A Larson, Sunil Gandhi, Delong Liu, Carmen Matei, Bart Scott, Kuolung Hu, Allen S Yang

Journal of Hematology & Oncology
A Randomized, Double-blind, Placebo-controlled Phase 2 Study Evaluating the Efficacy and Safety of Romiplostim Treatment of Patients with Low or Intermediate-1 Risk Myelodysplastic Syndrome Receiving Lenalidomide

Download full publication here.

Roger M Lyons
Azra Raza1, Naomi Galili1, Deborah Mulford, Scott E Smith, Gail L Brown, David P Steensma, Ralph Boccia, Mikkael A Sekeres, Guillermo Garcia-Manero, Ruben A Mesa

Journal of Hematology & Oncology
Phase 1 Dose-ranging Study of Ezatiostat Hydrochloride in Combination with Lenalidomide in Patients with Non-deletion (5q) Low to Intermediate-1 Risk Myelodysplastic Syndrome (MDS)

Download full publication here.

Berry, JS and Vreeland, TJ and Trappey, AF and Hale, DF and Clifton, GT and Sears, AK and Patil, R and Shumway, NM and Holmes, JP and McCall, S and others
Journal of Immunotherapy
Trends in Circulating Tumor Cells (CTCS) in Multiple Adjuvant (ADJ) Trials of HER2-Specific Peptide Vaccines (PV) in Breast Cancer (BRCA) PTS

John Sandbach, M.D. 
Hartman AR, Kaldate RR, Sailer LM, Painter L, Grier CE, Endsley RR, Griffin M, Hamilton SA, Frye CA, Silberman MA, Wenstrup RJ.

Myriad Genetic Laboratories, Inc.
Prevalence of BRCA mutations in an unselected population of triple-negative breast cancer.

Roger M Lyons
Srdan Verstovsek, M.D., Ph.D., Ruben A. Mesa, M.D., Jason Gotlib, M.D., Richard S. Levy, M.D., Vikas Gupta, M.D., John F. DiPersio, M.D., Ph.D., John V. Catalano, M.D., Michael Deininger, M.D., Ph.D., Carole Miller, M.D., Richard T. Silver, M.D., Moshe Talpaz, M.D., Elliott F. Winton, M.D., Jimmie H. Harvey, Jr., M.D., Murat O. Arcasoy, M.D., Elizabeth Hexner, M.D., Ronald Paquette, M.D., Azra Raza, M.D., Kris Vaddi, Ph.D., Susan Erickson-Viitanen, Ph.D., Iphigenia L. Koumenis, M.S., William Sun, Ph.D., Victor Sandor, M.D., and Hagop M. Kantarjian, M.D.

New England Journal of Medicine
A Double-Blind, Placebo-Controlled Trial of Ruxolitinib for Myelofibrosis

Download full publication here.

Chawla, Vij et al.
Transplant Infectious Diseases
Oral Valganciclovir as Pre-emptive Therapy for CMV-Positive Patients After Allogeneic Hematopoietic Stem Cell Transplant: A Randomized Trial and Review of the Literature

Roger Lyons
Ruben Mesa, Jason Gotlib, Richard Levy, Vikas Gupta, John DiPersio, John Catalono, Michael Deininger, Carloe Miller, Richard Silver, Moshe Talpaz, Elliott Winton, Jimmie Harvey, Murat Arcasoy, Elizabeth Hexner, Roger Lyons, Ronald Paquette, Azra Raza, Kris, Vaddi, Sue Erikson-Viitanen, Iphegenia Koumenis, William Sun, Victor Sandor, Hagop Kantarjian

16th Congress of the European Hematology Association
Results of Comfort-1, A Randomized, Double-Blind Phase III Trial of the JAK1 and JAK2 Inhibitor Ruxolitinib (INCB018424) Versus Placebo for Patients with Myelofibrosis

Download full publication here.

Jackson, G.L., Camacho, L.H.
2011 Cancer Program Annual Report, St. Luke’s Cancer Center
Cutaneous Melanoma Update: The St. Luke’s Episcopal Hospital Experience versus NCNB Statistics
Haney B, Shumway NM, Peoples GE
Advances in the Management of Triple Negative Breast Cancer
Advances in the Management of Triple Negative Breast Cancer Ch.9: Targeted therapies: other agents in clinical trials
Sears, AK and Clifton, GT and Patil, R and Shumway, NM and Carmichael, MG and Van Echo, DC and Holmes, JP and Ponniah, S and Mittendorf, EA and Peoples, GE
ASCO Annual Meeting Proceedings
Sequential administration of trastuzumab and a CD8 T-cell-eliciting HER2/neu peptide vaccine in patients with breast cancer compared to trastuzumab alone.
Clifton, GT and Sears, AK and Patil, R and Shumway, NM and Carmichael, MG and Van Echo, DC and Holmes, JP and McCall, S and Merrill, GA and Ponniah, S and others
ASCO Annual Meeting Proceedings
Monitoring of circulating tumor cell trends in a prospective, randomized, placebo-controlled HER2/neu peptide vaccine trial.

Roger M. Lyons
Srdan Verstovsek, MD, PhD, Ruben A. Mesa, MD, Jason Gotlib, MD, MS, Richard S. Levy, MD, Vikas Gupta, MD, FRCP, FRCPath, John F. DiPersio, MD, PhD, John Catalano, MD, Michael W. Deininger, Carole B. Miller, MD, Richard T. Silver, MD, Moshe Talpaz, MD, Elliott F. Winton, MD, Jimmie H. Harvey, Jr., MD, Murat O. Arcasoy, MD, Elizabeth Hexner, MD, Ronald Paquette, MD, PhD, Azra Raza, MD, Kris Vaddi, PhD, Sue Erickson-Viitanen, PhD, William Sun, PhD, Victor A. Sandor, MD, CM, Hagop M. Kantarjian

Blood
Clinical Burden and Progression of Myelofibrosis in a Controlled Study Population of Placebo-Treated Patients (COMFORT-1)

Download full publication here.

Roger M. Lyons
Azra Raza, MD, Naomi Galili, Ph.D., Deborah Mulford, MD, Scott E. Smith, MD, PhD, FACP, Gail Brown, MD, Lisa Meng, PhD, David P. Steensma, MD, Ralph Boccia, MD, Mikkael A. Sekeres, MD, MS, Guillermo Garcia-Manero, Ruben A. Mesa, MD

Blood
Phase I Dose-Ranging Study of Oral Ezatiostat Hydrochloride (Telintra, TLK199) in Combination with Lenalidomide (Revlimid) in Patients with Non-Deletion (5q) Low to Intermediate-1 Risk Myelodysplastic Syndrome (MDS)

Download full publication here.

Roger M. Lyons
Pierre Fenaux, MD, PhD, Hagop M. Kantarjian, Petra Muus, MD, PhD, Richard A. Larson, MD, Mikkael A. Sekeres, MD, MS, Pamela S. Becker, MD, PhD, Catherine Jia, PhD, Allen S. Yang, MD, PhD

Blood
Update of an Open-Label Extension Study Evaluating the Long-Term Safety & Efficacy of Romiplostim in Thrombocytopenic Patients with Myelodysplastic Syndromes (MDS)

Download full publication here.

Roger M. Lyons, MD
Srdan Verstovsek, MD, PhD, Ruben A. Mesa, MD, Jason Gotlib, MD, MS, Richard S. Levy, MD, Vikas Gupta, MD, FRCP, FRCPath, John F. DiPersio, MD, PhD, John Catalano, MD, Michael W. Deininger, Carole B. Miller, MD, Richard T. Silver, MD, Moshe Talpaz, MD, Elliott F. Winton, MD, Jimmie H. Harvey Jr., MD, Murat O. Arcasoy, MD, Elizabeth Hexner, MD, Ronald Paquette, MD, PhD, Azra Raza, MD, Kris Vaddi, PhD, Sue Erickson-Viitanen, PhD, William Sun, PhD, Victor A. Sandor, MD, CM, Hagop M. Kantarjian

Blood
Consistent Benefit of Ruxolitinib Over Placebo in Spleen Volume Reduction and Symptom Improvement Across Subgroups and Overall Survival Advantage: Results From COMFORT-1

Download full publication here.

Roger M. Lyons, MD
Jeffrey Wasser, MD, Ralph Vincent V. Boccia, MD, Romeo Mandanas, Ingrid Pabinger, Marc Michel IV, Jean-François Viallard, MD-PhD, Xuena Wang, PhD, Richard Lizambri, MD

Blood
Use of Rituximab in a Study Comparing the Thrombopoietin Mimetic Romiplostim with Standard of Care (SOC) in Patients with Immune Thrombocytopenia (ITP)

Download full publication here.

Roger M. Lyons, MD
Billie J. Marek1, Surabhi Sharma, Carole Paley, Jason Esposito, Lawrence Garbo, MD, NicholasnDiBella1, Guillermo Garcia-Manero

Blood
24-Month Analysis of the Impact of Chelation on Clinical Outcomes in 600 Patient Registry of Lower-Risk MDS Patients

Download full publication here.

Roger M. Lyons, MD
David J. Kuter, MD, DPhil, James B. Bussel, MD, Adrian Newland, FRCP, Jeffrey S. Wasser, MD, James N. George, MD, Gail Macik, MD, Kun Nie, Susie Jun

Blood
Long-Term Efficacy and Safety of Romiplostim Treatment of Adult Patients with Chronic Immune Thrombocytopenia (ITP): Final Report from an Open-Label Extension Study

Download full publication here.

Sears, Alan K and Perez, Sonia A and Clifton, Guy T and Benavides, Linda C and Gates, Jeremy D and Clive, Kevin S and Holmes, Jarrod P and Shumway, Nathan M and Van Echo, David C and Carmichael, Mark G and others
Expert Opinion on Biological Therapy
AE37: a novel T-cell-eliciting vaccine for breast cancer

Roger M Lyons
Craig Reynolds, Nicholas Di Bella, William Hyman, Donald A. Richards, Gerald J. Robbins, Mark Vellek, Kristi A. Boehm, Feng Zhan & Lina Asmar

Investigational New Drugs
A Phase III Trial of Fludarabine, Cyclophosphamide, and Rituximab vs. Pentostatin, Cyclophosphamide, and Rituximab in B-Cell Chronic Lymphocytic Leukemia

Download full publication here.

Patt D, Espirito J, Turnwald B, Hoverman J, Neubauer M, Busby L, Brooks, Kolodziej, Anderson R, Beveridge R
JCO Supplements
Utilization of pegfilgrastim in adjuvant chemotherapy regimens for breast cancer in the community
Chen C, Patt D, Kazzaz D, Shankleton J, Forsyth M, Ganesh R
JCO Supplements
Evaluating utilization characteristics for the Oncotype DX recurrence score in early-stage breast cancer
Ginsburg A, Patt D, Flinn J, Espirito J, Neubauer M, Cartwright T, Hoverman J, Busby B, Brooks, B Kolodziej M, Sitarik M, Anderson R, Beveridge R
JCO Supplements
Understanding male breast cancer in the community setting
Patt D, Espirito J, Turnwald B, Hoverman J, Neubauer M, Cartwright T, Brooks B, Busby L, Sitarik M, Kolodziej M, Ginsburg A, Sheth S, Garey J, Clayton M, Nelson R, Anderson R, Beveridge R
JCO Supplements
Utilization and relative value of breast cancer adjuvant chemotherapy regimens in the community

Roger M. Lyons
Sharon T Wilks, Shelby Young, Gail L Brown

Journal of Hematology & Oncology
Oral Ezatiostat HCl (Telintra, TLK199) and Idiopathic Chronic Neutropenia (ICN): A Case Report of Complete Response of a Patient with G-CSF Resistant ICN Following Treatment with Ezatiostat, a Glutathionie S-transferase P1-1 (GSTP1-1) Inhibitor

Download full publication here.

Kolodziej M, Hoverman JR, Garey JS, Espirito J, Sheth S, Ginsburg A, Neubauer MA, Patt D, Brooks B, White C, Sitarik M, Anderson R, Beveridge R
Journal of Oncology Practice
Benchmarks for value in cancer care: an analysis of a large commercial population
Hoverman, JR. Cartwright TH. Patt, DA. Espirito, JL. Clayton, MP. Garey, JS. Kopp, TJ. Kolodziej, M. Neubauer, M. Fitch, K. Pyenson, B. Beveridge, RA
Journal of Oncology Practice
Pathways, Outcomes, and Costs in Colon Cancer:  Retrospective evaluations in two distinct databases

Roger M Lyons
David Claxton, Harry P. Erba, Stefan Faderl, Martha Arellano, Tibor Kovacsovics, Janice Gabrilove, Dirk Huebner, Pritesh J. Gandhi, Hagop Kantarjian

Leukemia and Lymphoma
Outpatient Consolidation Treatment with Clofarabine in a Phase 2 Study of Older Adult Patients with Previously Untreated Acute Myelogenous Leukemia (AML)

Download full publication here.

R.M. Lyons
P. Fenaux, H. Kantarjian, R.A. Larson, M.A. Sekeres, P.S. Becker, P. Muus, C. Jia, A.S. Yang

Leukemia Research
Update of an Open-Label Extension Study Evaluating the Long-Term Safety & Efficacy of Romiplostim in Thrombocytopenic Patients with Myelodysplastic Syndromes

Download full publication here.

R.M. Lyons
G. Garcia-Manero, B.J. Marek, N. Martinez-Lopez, J. Esposito, C. Paley, N. DiBella

Leukemia Research
A 12-Month Follow-Up of an Ongoing Prospective, Non-Interventional, Multicenter Registry in Iron Overloaded Patients with Lower-Risk Myelodysplastic Syndromes

Download full publication here.

O’Shaughnessy, J. Osborne, C. Pippen, JE. Yoffee, M. Patt, D. Rocha C. Koo, IC. Sherman BM. Bradley, C.
New England Journal of Medicine
Iniparib plus Chemotherapy n Metastatic Triple-Negative Breast Cancer
Jackson, G. L.
2010 Kelsey Seybold Clinic Annual Report
Malignant Melanoma, Diagnosis and Treatment

Roger M. Lyons
Nicholas Di Bella, Raymond Taetle, Kathryn Kolibaba, Thomas Boyd, Robert Raju, David Barrera, Ernest W. Cochran Jr, Philip Y. Dien, Peter J. Schlegel, Svetislava J. Vukelja, Julie Boston, Kristi A. Boehm, Yunfei Wang, Lina Asmar

Blood
Results of a Phase II Study of Bortezomib in Patients with Relapsed or Refractory Indolent Lymphoma

Download full publication here.

Roger M. Lyons, MD
Pierre Fenaux, MD, PhD, Hagop Kantarjian, MD, Richard A Larson, MD, Mikkael A Sekeres, MD, MS, Pamela Becker, MD, PhD, Petra Muus, MD, PhD, Catherine Jia, PhD,8 Allen S Yang, MD, PhD

 

Blood
Update from an Open-Label Extension Study Evaluating the Long-Term Safety and Efficacy of Romiplostim in Thrombocytopenic Patients with Myelodysplastic Syndromes

Download full publication here.

Sandbach J
Eisenbraun A, Wenstrup R, Fry C, Reid, J, Hellerstedt, B, and Sailer, L

Community Oncology
Hereditary Breast and Ovarian Cancer Testing Integration and Outcomes within Community Oncology Practices.

Roger M. Lyons
Hagop Kantarjian, Pierre Fenaux, Mikkael A. Sekeres, Pamela S. Becker, Adam Boruchov, David Bowen, Eva Hellstrom-Lindberg, Richard A. Larson, Petra Muus, Jamile Shammo, Robert Siegel, Kuolung Hu, Janet Franklin, Dietmar P. Berger

Journal of Clinical Oncology
Safety and Efficacy of Romiplostim in Patient with Lower-risk Myelodysplastic Syndrome (MDS) and Thrombocytopenia

Download full publication here.

Roger M. Lyons
Hagop M. Kantarjian, Harry P. Erba, David Claxton, Martha Arellano, Tibor Kovascovics, Janice Gabrilove, Michael Craig, Dan Douer, Michael Maris, Stephen Petersdorf, Paul J. Shami, Andrew M. Yeager, Stephen Eckert, Rekha Abichandani, and Stefan Faderl

Journal of Clinical Oncology
Phase II Study of Clofarabine Monotherapy in Previously Untreated Older Adults with Acute Myeloid Leukemia and Unfavorable Prognostic Factors

Download full publication here.

Sandbach J
Loesch D, Greco FA, Senzer NN, Burris HA, Hainsworth JD, Jones S, Vukelja SJ, Holmes F, Sedlacek S, Pippen J, Lindquist D, McIntyre K, Blum JL, Modiano MR, Boehm KA, Zhan F, Asmar L, Robert N.

Journal of Clinical Oncology
Phase III Multicenter Trial of Doxorubicin Plus Cyclophosphamide Followed by Paclitaxel Compared With Doxorubicin Plus Paclitaxel Followed by Weekly Paclitaxel As Adjuvant Therapy for Women With High-Risk Breast Cancer.
Neubauer, MA. Espirito, JL, Clayton, M. Patt, DA.
Journal of Clinical Oncology
Combination versus sequential chemotherapy for metastatic breast cancer: An evaluation of outcomes from a community oncology network

Barrera, David N. D.O. 
Nicholas Di Bella, Raymond Taetle, Kathryn Kolibaba, Thomas Boyd, Robert Raju, David Barrera, Ernest W. Cochran, Jr, Philip Y. Dien, Roger Lyons, Peter J. Schlegel, Svetislava J. Vukelja, Julie Boston, Kristi A. Boehm, Yunfei Wang, and Lina Asmar 

Journal of the American Society of Hematology
Results of a phase 2 study of bortezomib in patients with relapsed or refractory indolent lymphoma
Socinski, MA. Raju, RN. Stinchombe, T. Kocs, DM. Couch, LS.Barrera, D. Rousey, SR. Choksi, JK. Jotte, R. Patt, DA. Periman, PO. Schlossberg, HR. Weissman, CH. Wang, Y. Asmar, L. Pritchard, S. Bromund J. Peng, G. Treat, J. Obasaju, CK.
Journal of Thoracic Oncology
Randomized phase II trial of pemetrexed and carboplatin with or without enzastaurin versus docetaxel and carboplatin as first-line treatment of patients with stage IIIB/IV non-small cell lung cancer
Scholl, P. Snyder, N. Patt, D. Talbott, B
Otolaryngology-Head and Neck Surgery
Pilomatrical carcinosarcoma
Patt, D, Espirito, J, Turnwald, B, Hoang, S, Hoverman, J.
Proceedings ASCO Breast Cancer Symposium
Ixabepilone alone and in combination with chemotherapy in the community setting
Chawla & Ellis
Surgical Oncology Clinics of North America
A Review of Neoadjuvant Endocrine Therapy for Breast Cancer 
Shumway, NM and Terrazzino, SE and Jones, CB
ASCO Annual Meeting Proceedings
A randomized pilot study comparing aprepitant to olanzapine for treatment of chemotherapy-induced nausea and vomiting
Shumway, Nathan M and Ibrahim, Nuhad and Ponniah, Sathibalan and Peoples, George E and Murray, James L
BioDrugs
Therapeutic Breast Cancer Vaccines

Roger M. Lyons
James B. Bussel, David J. Kuter, Vinod Pullarkat, Matthew Guo, Janet L. Nichol

Blood
Safety and Efficacy of Long-Term Treatment with Romiplostim in Thrombocytopenic Patients with ITP

Download full publication here.

Roger M. Lyons, MD
Guillermo Garcia-Manero, Billie J. Marek, Noelia Martinez-Lopez, Carole Paley, Peter L. Greenberg

Blood
Clinical Parameters in 391 Iron-Overloaded Patients with Lower-Risk MDS Enrolled in a Prospective, Non-Interventional Multicenter Registry

Download full publication here.

Roger M. Lyons
Stefan Faderl, MD, Harry P Erba, David F. Claxton, M.D., M. Arellano, Tibor J. Kovacsovics, MD, Janice Gabrilove, MD, Elizabeth Anderson, Elly Barry, MD, Hagop M. Kantarjian, MD

Blood
Outpatient Treatment with Clofarabine in Phase II Study of Older Adult Patients with Previously Untreated Acute Myelogenous Leukemia

Download full publication here.

Roger M. Lyons
Stefan Fader, MD, Harry P Erba, David F. Claxton, M.D, M. Arellano,  Tibor J. Kovacsovics, MD, Janice Gabrilove, MD, Elizabeth Anderson, Elly Barry, MD, Hagop M. Kantarjian, MD

Blood
Clorfarabine Produces Durable Remissions in Older Patients with AML with Unfavorable Prognostic Factors and Multiple Comorbidities

Download full publication here.

Roger M. Lyons
Harry P Erba, Stefan Fader, MD, David F. Claxton, MD, M. Arellano, Tibor J. Kovacsovics, MD, Janice Gabrilove, MD, Stephen Eckert, Ph.D, Dirk Huebner, MD, Hagop M. Kantarjian, MD

Blood
Single-Agent Clofarabine Produces Durable Remissions in Patients with Acute Myelogenous Leukemia (AML) Who > or = 70, Have Intermediate or Unfavorable Cytogenetics, Antecedent Hematological Disorders (AHD), or 2 or More Unfavorable Prognostic Factors

Download full publication here.

Roger M Lyons
Richard A. Larson, MD, Michael A. Kosmo, MD, Sunil Gandhi, Delong Liu, MD, PhD, Marc Chernoff, Luke Dreisbach, MD, Carmen Matei, Kuolong Hu, Ph, Janet L. Franklin, MD, MPH, Dietmar Berger, MD, PhD

Blood
Randomized Phase II Study Evaluating the Efficacy and Safety of Romiplostim Treatment of Patients with Low or Intermediate Risk Myelodysplastic Syndrome (MDS) Receiving Lenalidomide

Download full publication here.

Roger M Lyons
Janice Gabrilove, MD, Stefan Fader, MD, Harry P Erba, David F. Claxton, M.D., M. Arellano, Tibor J. Kovacsovics, MD, Stephen Eckert, Ph.D, Dirk Huebner, MD, Hagop M. Kantarjian, MD

Blood
Complete Response to Clofarabine Is Durable and Correlates with Survival in Previously Untreated Older Adults with Acute Myeloid Leukemia (AML) and Unfavorable Prognostic Factors

Download full publication here.

Roger M Lyons
Pierre Fenaux, Hagop Kantarjian, MD, Richard A. Larson, MD, Mikkael A. Sekeres, MD, MS, Pamela S. Becker, MD, PhD, Petra Muus, MD, PhD, Kuolong Hu, PhD, Dietmar Berger, MD, PhD, Janet L. Franklin, MD, MPH

Blood
An Open-Label Extension Study Evaluating the Long-Term Safety and Efficacy of Romiplostim in Thrombocytopenic Patients with Myelodysplastic Syndromes (MDS)

Download full publication here.

Roger M Lyons
Ralph V. Boccia, MD, Gail Macik, MD, Romeo A. Mandanas, MD, FACP, Xuena Wang, Richard Lizambri, MD,d Dietmar Berger, MD, PhD

Blood
Home Administration of Romiplostim by Patients with Chronic Immune Thrombocytopenia (ITP)

Download full publication here.

Roger M. Lyons
JN George, SD Mathias, RS Go RS, M Guo, DH Henry, RL Redner, L Rice, MR Schipperus

British Journal of Haematology
Improved Quality of Life for Romiplostim-Treated Patients with Chronic Immune Thormbocytopenic Purpura: Results from Two Randomized, Placebo-Controlled Trials

Roger M. Lyons, M.D., F.A.C.P.
Jamile M. Shammo, M.D., F.A.S.C.P., Lewis R. Silverman, M.D., Bart L. Scott, M.D.

Clinical Advances in Hematology & Oncology
Treatment Selection for Myelodysplastic Syndrome Patients in a Community Setting 

Download full publication here.

Roger M. Lyons
Thomas M. Cosgriff, Sanjiv S. Modi, Robert H. Gersh, John D. Hainsworth, Allen L. Cohn, Heidi J. McIntyre, Indra J. Fernando, Jay T. Backstrom, C.L. Beach

Journal of Clinical Oncology
Hematologic Response to Three Alternative Dosing Schedules of Azacitidine in Patients with Myelodysplastic Syndromes

Download full publication here.

R. M. Lyons
H. P. Erba, H. M. Kantarjian, D. F. Claxton, M. Arellano, T. J. Kovacsovics, J., Gabrilove, S. Eckert, S. Faderl

Journal of Clinical Oncology
Updated Remission Duration and Survival Results of Single-agent Clofarabine in Previously Untreated Older Adult Patients with Acute Myelogenous Leukemia Unlikely to Benefit From Standard Induction Chemotherapy Due to Unfavorable Baseline Risk Factor(s)

Download full publication here.

Chawla, Jane S.
Washington University in St. Louis
In Pursuit of Personalized Therapy for Breast Cancer: Gene Expression Signatures
Chawla, Jane S.
Washington University in St. Louis
A Phase II Study of Gemcitabine and a Multi-kinase Inhibitor in Metastatic Pancreatic Cancer
Chawla, Jane S.
Washington University in St. Louis
Neoadjuvant Chemotherapy for Rectal Cancer
Zhao, Sperry (Chawla), & Freeman et al.
Cancer Research
Inhibition of STAT3Tyr705 Phosphorylation by Smad4 Suppresses Transforming Growth Factor B–Mediated Invasion and Metastasis in Pancreatic Cancer Cells 

Hoverman, J. Russell M.D. 
Radebaugh, K.A.

American Society Clinical Oncology
Imaging in Early Breast Cancer

McCollum, David M.D. 
Richards D, Wilfong L, Sborov M, Boehm KA, Zhan F, and Asmar L.

Annals of Oncology
Phase II trial of docetaxel and oxaliplatin in patients with advanced gastric cancer and/or adenocarcinoma of the gastroesophageal junction.

Roger M. Lyons, MD
Nicholas Di Bella, MD, Raymond Taetle, MD, Kathryn S. Kolibaba, MD, Thomas E Boyd, MD, Robert N Raju, MD, David N Barrera, DO, Ernest Cochran, MD, Philip Dien, MD, David Hakimian, MD, Peter J Schlegel, MD, Svetislava J Vukelja, MD, Julie Boston, RN, Kristi A Boehm, MS, Yunfei Wang, MS, Lina Asmar, PhD

Blood
Results of a Phase II Study of Bortezomib in Patients with Relapsed or refractory Indolent Lymphoma

Download full publication here.

Roger M. Lyons, MD
Craig Reynolds, MD, Nicholas Di Bella, MD, William J Hyman, MD, Gary L. Lee, MD, Donald A Richards, MD, PhD, Gerald J. Robbins, MD, Mark Vellek, MD, Kristi A Boehm, MS, Feng Zhan, PhD, Lina Asmar, PhD

Blood
Phase III Trial of Fludarabine, Cyclophosphamide, and Rituximab Vs. Pentostatin, Cyclophosphamide, and Rituximab in B-Cell Chronic Lymphocytic Leukemia

Download full publication here.

Roger M. Lyons, MD
Harry Paul Erba, MD, PhD, Hagop Kantarjian, David F. Claxton, MD, M. Arellano4, Tibor J. Kovacsovics, MD, Janice Gabrilove, MD, Stephen Eckert, Ph.D, Rekha Abichandani, MD, Stefan Faderl, MD

Blood
Phase II Study of Single Agent Clofarabine in Previously Untreated Older Adult Patients with Acute Myelogenous Leukemia (AML) Unlikely to Benefit from Standard Induction Chemotherapy

Download full publication here.

Roger M. Lyons, MD
James George, MD, James B Bussel, MD, Vinod Pullarkat, MD, Robert Redner, MD, Deirdra Terrell, PhD, Kun Nie, PhD, Dietmar Berger, MD, PhD

Blood
Self-Injection of Romiplostim by Patients with Chronic Immune Thrombocytopenic Purpura (ITP)

Download full publication here.

Roger M. Lyons, MD
James B. Bussel, David J. Kuter, Vinod Pullarkat, Matthew Guo, Janet L. Nichol

Blood
Safety and Efficacy of Long-Term Treatment with Romiplostim in Thrombocytopenic Patients with ITP

Download full publication here.

Lim, S.H. M.D. 
Zhang, Y., Burris, C. and Townsend, M.

Bone Marrow Transplant

Successful salvage with unrelated umbilical cord blood transplant for Hodgkin’s disease relapsed following autologous stem cell transplant.

Esler, William Vance, M.D. 
Lim, S.H., Periman, P.O., Beggs, D., Zhang, Y., and Townsend, M.

British Journal of Haematology
R-CHOP followed by consolidative autologous stem cell transplant and low dose rituxan maintenance therapy for advanced mantle cell lymphoma

Roger M. Lyons
Janice Gabrilove, Ronald Paquette, Chaudhry Mushtaq, Mikkael A. Sekeres, Dianne Tomita, Lyndah Dreiling

British Journal of Haematology
Phase 2, Single-arm, Trial to Evaluate the Effectiveness of Darbopoetin alfa for Correcting Anaemia in Patients with Myelodysplastic Syndromes

Download full publication here.

Roger M. Lyons, MD, FACP
Richard Stone, MD, Mikkael Sekeres, MD, MS, Guillermo Garcia-Manero, MD

Clinical Advances in Hematology & Oncology
Recent Advances in Low- and Intermediate-1--Risk Myelodysplastic Syndrome: Developing a Consensus for Optimal Therapy

Download full publication here.

Hutson, Thomas E. D.O., PharmD, FACP
MD Galsky.

Expert Review of Anticancer Therapy
Current optimal chemotherapy for advanced urothelial cancer.

R Lyons
T. Cosgriff, S. Modi, H. McIntyre, I. Fernando, J. Backstrom, C.L. Beach

Haematologica
Rapid Onset of Effectiveness with Three Alternative Azacitidine (AZA) Dosing Regimens in Patients with Myelodysplastic Syndromes (MDS)

Download full publication here.

R. Lyons
H. P. Erba, H. M. Kantarjian, D. Claxton, M. Arellano, T. Kovacsovics, J. Gabrilove, S. Eckert, R. Abichandani, S. Faderl

Journal of Clinical Oncology
Phase II Study of Single Agent Clofarabine in Previously Untreated Older Adult Patients with Acute Myelogenous leukemia (AML) Unlikely to Benefit from Standard Induction Chemotherapy

Download full publication here.

Jones, Stephen E. M.D. 
Luc Yves Dirix, Jorge Ignacio, Shona Nag, Poonamally Bapsy, Henry Gomez, Digumarti Raghunadharao, Robert Paridaens, Silvia Falcon, Marina Carpentieri, Antonello Abbattista, Jean-Pierre Lobelle

Journal of Clinical Oncology

Treatment of Advanced Hormone-Sensitive Breast Cancer in Postmenopausal Women With Exemestane Alone or in Combination with Celecoxib

Weiss, Brendan M and Shumway, Nathan M and Howard, Robin S and Ketchum, Lloyd K and Reid, Thomas J
Journal of Thrombosis and Thrombolysis
Optical density values correlate with the clinical probability of heparin induced thrombocytopenia

Roger M. Lyons
David J Kuter, James B Bussel, Vinod Pullarkat, Terry B Gernsheimer, Francis M Senecal, Louis M Aledort, James N George, Craig M Kessler, Miguel A Sanz, Howard A Liebman, Frank T Slovick, J Th M de Wolf, Emmanuelle Bourgeois, Troy H Guthrie Jr, Adrian Newland, Jeff rey S Wasser, Solomon I Hamburg, Carlos Grande, François Lefrère, Alan Eli Lichtin, Michael D Tarantino, Howard R Terebelo, Jean-François Viallard, Francis J Cuevas, Ronald S Go, David H Henry, Robert L Redner, Lawrence Rice, Martin R Schipperus, D Matthew Guo, Janet L Nichol

Lancet
Efficacy of Romiplostim in Patients with Chronic Immune Thrombocytopenic Purpura: a Double-blind Randomised Controlled Trial

Download full publication here.

Esler, William Vance, M.D. 
Lim, S.H., Zhang, Y., Zhang, J., Periman, P.O., Burris, C., Townsend, M.

Leukemia and Lymphoma
B-cell depletion for 2 years after autologous stem cell transplant for NHL induces prolonged hypogammaglobulinemia beyond the rituximab maintenance period.
Shumway, Nathan M and Wilson, Ramey L and Howard, Robin S and Parker, Joseph M and Eliasson, Arn H
Respiratory Medicine
Presence and treatment of air hunger in severely ill patients
Chawla, Jane S.
UT Southwestern
Paroxysmal Nocturnal Hemoglobinuria
Chawla, Jane S.
Washington University in St. Louis
The Natural Killer Cell Neoplasms: Can We Overcome Treatment Resistance?

John Sandbach, MD
David Loesch, MD; F. Anthony Greco, MD; Joyce O'Shaughnessy, MD; Nicholas Robert, MD; Neil N. Senzer, MD; John D. Hainsworth, MD; Sasha Vukelja, MD; Frankie Holmes, MD; Scot Sedlacek, MD; Deborah Lindquist, MD; Jario Olivares, MD; Kristi A. Boehm, MS; Feng Zhan, PhD; Lina Asmar, PhD

ASC Journal of Clinical Oncology
A randomized, multicenter phase III trial comparing regimens of doxorubicin + cyclophosphamide followed by paclitaxel or doxorubicin + paclitaxel followed by weekly paclitaxel as adjuvant therapy for patients with high risk breast cancer

R. Lyons
T. Cosgriff, S. Modi, H. McIntyre, I. Fernando, J. Backstrom, C. L. Beach

Blood
Results of the Initial Treatment Phase of a Study of Three Alternative Dosing Schedules of Azacitidine (Vidaza) in Patients with Myelodysplastic Syndromes (MDS)

Download full publication here.

Roger Lyons
James N. George, Francois Lefrere, Alan E. Lichtin, Michael D. Tarantino, Howard R. Terebelo, Jean-Francois Viallard, Reggie Kelly, Matthew Guo, Janet Nichol

Blood
Evaluation of AMG 531 Safety in Splenectomized (S) and Nonsplenectomized (NS) Patients with Chronic Immune Thrombocytopenic Purpura (ITP) in Two Randomized Placebo-Controlled Phase 3 Studies

Download full publication here.

Roger Lyons
James N. George, Francis J. Cuevas, Ronald S. Go, David H. Henry, Robert L. Redner, Lawrence Rice, Martin R. Schipperus, Susan D. Mathias, Sue Gao, Matthew Guo, Janet L. Nichol

Blood
Health-Related Quality of Life (HRQoL) in Patients with Chronic Immune Thrombocytopenic Purpura (ITP): Results from Two Placebo-Controlled Phase 3 Studies of AMG 531

Download full publication here.

Roger Lyons
Hagop Kantarjian, Pierre Fenaux, Mikkael A. Sekeres, Pamela Becker, Adam Boruchov, David Bowen, Richard Larson, Petra Muus, Jamile Shammo, Michael Ehrman, Kuolung Hu, Janet Nichol

Blood
Phase 1/2 Study of AMG 531 in Thrombocytopenic Patients with Low Risk Myelodysplastic Syndrome (MDS): Update on Extended Treatment

Download full publication here.

Roger Lyons
Kantarjian H, Giles F, List A, Sekeres MA, Pierce S, Deuson R, Leveque J.

Cancer
The Incidence and Impact of Thrombocytopenia in Myelodysplastic Syndromes

Download full publication here.

R. M. Lyons
T. Cosgriff, S. Modi, H. McIntyre, C. L. Beach, J. T. Backstrom

Journal of Clinical Oncology
Tolerability and Hematologic Improvement Assessed Using Three Alternative Dosing Schedules of Azacitidine in Patients with Myelodysplastic Syndromes

Download full publication here.

R.M. Lyons
T. Cosgriff, S. Modi, H. McIntyre, C. L. Beach, J. T. Backstrom

Journal of Clinical Oncology
Baseline Predictors of Response to Treatment with Darbepoeitin-alpha (DA) in Anemic Patients with Low-risk Myelodysplastic Syndrome (MDS)

Download full publication here.

R. M. Lyons
H. M. Kantarjian, F. J. Giles, P. Fenaux, P. S. Becker, A. M. Boruchov, D. T. Bowen, E. Hellström-Lindberg, R. A. Larson, P. Muus

Journal of Clinical Oncology
Evaluating Safety and Efficacy of AMG 531 for the Treatment of Thrombocytopenic Patients with Myelodysplastic Syndrome (MDS): Preliminary Results of a Phase 1/2 Study

Download full publication here.

Roger Lyons
Hagop M. Kantarjian, Francis Giles, Alan F. List, Roger Lyons, Sherry Price, Robert Deuson, Joseph Leveque

Journal of Community and Supportive Oncology
The Incidence and Impact of Thrombocytopenia in Myelodysplastic Syndrome

Download full publication here.

R. M. Lyons
H.M. Kantarjian, F.J. Giles, P. Fenaux, P.S. Becker, A.M. Boruchov, D. Bowen, E. Hellstrom-Lindberg, R.A. Larson, R.M. Lyons, P. Muus

Journal of Community and Supportive Oncology
The Efficacy and Safety of Darbopoetin Alfa For Treating Anemia in Low-Risk Myelodysplastic Syndrome Patients: Results After 53-55 Weeks

Download full publication here.

Roger Lyons
David Kuter, James B. Bussel, James George, Louis Aledort, Alan Lichtin, Roger Lyons, Jorge Nieva, Jeffrey Wasser, Emanuelle Bourgeois, Mies Kappers-Klunne, Francois Lefrere, Martin Schipperus, Reggie Kelly, Jenny Christal, Matthew Guo, and Janet Nichol

Journal of Community and Supportive Oncology
Long-term Dosing of AMG 531 in Thrombocytopenic Patients with Immune Thrombocytopenic Purpura: 48-week Update

Download full publication here.

R. Lyons
H.M. Kantarjian1, F. Giles, A.F. List, M. Sekeres4, S. Pierce1, R. Deuson, J. Leveque

Supportive Care Cancer
Thrombocytopenia in MDS: Incidence and Impact

Download full publication here.

R. M. Lyons
H.M. Kantarjian, F.J. Giles, P. Fenaux, P.S. Becker, A.M. Boruchov, D. Bowen, E. Hellstrom-Lindberg, R.A. Larson, R.M. Lyons, P. Muus

Supportive Care Cancer
Evaluating Safety and Efficacy of AMG 531 for the Treatment of Thrombocytopenic Patients with Myelodysplastic Syndrome (MDS): Preliminary Results of a Phase 1/2 Study

Download full publication here.

Hutson, Thomas E. DO, PharmD, FACP 
RA Figlin

The Cancer Journal
Renal Cell Carcinoma: Recent Advances.

Barker Jr., Jerry L., M.D. 
O’Daniel JC, Rosenthal DI, Garden AS, Ahamad A, Ang KK, Asper JA, Blanco AI, de Crevoisier R, Holsinger FC, Patel CB, Schwartz DL, Wang H, Dong L.

American Journal of Clinical Oncology
The effect of dental artifacts, contrast media, and experience on interobserver contouring variations in head and neck anatomy.

Shivnani, Anand M.D. 
 Small W Jr., Stryker SJ, et al.

American Journal of Surgery
Preoperative chemoradiation in rectal cancer: results of multimodality management and analysis of prognostic factors.

Hutson, Thomas E. DO, PharmD, FACP 

Baylor Health Care Center Proceedings
Targeted therapy for renal cell carcinoma: A new treatment paradigm

Estil A. Vance III, M.D. 
Drew J. Winson, Jo-Anne H. Young, Vinod Pullarkat, Genovefa A. Papanicolaou, Ravi Vij, George J. Alangaden, Roy F., Chemaly, Finn Petersen, Nelson Chao, Jared Klein, Kellie Sprague, Stephen A. Villano, and Michael Boeckh.

Blood
Maribavir prophylaxis for prevention of cytomegalovirus infection in allogeneic stem-cell transplant recipients: a multicenter, randomized, double-blind, placebo-controlled, dose-ranging study.

Hutson, Thomas E. DO, PharmD, FACP 
T Powles, CJ Sweeney, MD Galsky, N Hahn, and CN Sternberg.

British Journal of Urology International
Novel agents for urothelial cancer: review

Hutson, Thomas E. DO, PharmD, FACP 
K Chi, T Powles, CJ Sweeney, N Hahn, MD Galsky, WR Berry and D Kadman

Cancer
Neoadjuvant therapy followed by prostatectomy for clinically localized prostate cancer.

Roger Lyons, MD
Hagop Kantarjian, MD, Francis Giles, MD, Alan List, MD, Mikkael A. Sekeres, MD, Sherry Pierce, BSN, Robert Deuson, PhD, Joseph Leveque, MD

Cancer
The Incidence and Impact of Thrombocytopenia in Myelodysplastic Syndromes

Download full publication here.

Hutson, Thomas E. DO, PharmD, FACP 
George, T Mekhail, L Wood, J Finke, P Elson, R Dreicer, and RM Bukowski.

Cancer Chemotherapy and Pharmacology
Phase I trial of PEG-Intron and rIL-2 in patients with metastatic renal cell carcinoma

Pippen, John E., JR. MD, F.A.C.P. 
Blum J, Savin M, Edelamn G, et al.

Clinical Breast Cancer
Phase II study of weekly albumin bound paclitaxel for patients with breast cancer heavily pretreated with taxanes.

Blum, Joanne L. M.D., Ph.D. 
Freibel TM, Domcheck SM, Neuhausen SL, Wagner T, Evans DG, Isaacs C, Garber JE, Daly MB, Eeles R, Matloff E, Tomlinson G, Lynch HT, Tung N, Weitzel J, Rubinstein WS, Ganz PA, Couch F, Rebbeck TR.

Clinical Breast Cancer
Bilateral prophylactic oophorectomy and bilateral prophylactic mastectomy in a prospective cohort of unaffected BRCA1 and BRCA2 Mutation Carriers.

Blum, Joanne L. M.D., Ph.D. 
Savin M, Edelman G, Pippen J, Robert N, Geister B, Kirby R, Clawson A, O’Shaughessy J.

Clinical Breast Cancer
Phase 2 study of weekly nab-Paclitaxel for the treatment of patients with metastatic breast cancer heavily pretreated with taxanes.

Hutson, Thomas E. DO, PharmD, FACP

Current Oncology Report
A novel multitargeted tyrosine kinase inhibitor.

Hutson, Thomas E. DO, PharmD, FACP

Expert Opinion on Biological Therapy
Recent advances in the therapy of renal cancer.

Hutson, Thomas E. DO, PharmD, FACP 

Expert Review of Anticavity Therapy
Safety and tolerability of sorafenib in clear-cell renal cell carcinoma – a phase III overview.

Blum, Joanne L. M.D., Ph. D. 
Kauff ND, Domcheck SM, Freibel TM, Robson ME, Lee J, Garber JE, Isaacs C, Evans DG, Lynch HT, Eeles RA, Neuhasusen SL, Daly MB, Matloff E, Norton L, Offit K, Rebbeck TR.

Journal of Clinical Oncology
Recall injury from vinblastine: a case report.

Fay, Joseph Wayne, M.D. 
Palucka A, Banchereau J, Vence L, Connolly J, Uneo H.

Journal of Clinical Oncology
Compresensive analysis of melanoma antigen specific T cell repertoire. EPIMAX (Epitope MAXimum)

Fay, Joseph Wayne, M.D. 
Banchereau, J., Palucka, K

Journal of Clinical Oncology
Long-term survival in patients with metastatic melanoma vaccinated with melanoma-antigen loaded dendritic cells.

Hoverman, J. Russell M.D. 
et. al.

Journal of Clinical Oncology
Assessment of medication safety in the outpatient setting.

Pippen, John E., JR. MD, F.A.C.P. 
Jones SE, Cantrell J, Vukelja S, et al.

Journal of Clinical Oncology
Comparison of menopausal symptoms during the first year of adjuvant therapy with either exemestane or tamoxifen in early breast cancer: a report of a tamoxifen exemestane adjuvant multicenter trial substudy.

Patt, Debra M.D. 
Duan, Zhigang. Fang, Shenying. Hortobagyi, Gabriel N. and Giordano, Sharon H.

Journal of Clinical Oncology
Acute Myeloid Leukemia after Adjuvant Breast Cancer Therapy in Older Women: Understanding Risk.

Mennel, Robert G. M.D., FACP 
Harris L, Fritsche H, Norton L, Ravdin P, Taube S, Somerfield MR, Hayes DF. Bast RC Jr.

Journal of Clinical Oncology
American Society of Clinical Oncology 2007 update of recommendations for the use of tumor markers in breast cancer.

Pippen, John E., JR. MD, F.A.C.P. 

Journal of Oncology Practice
Maintenance of certification: my perspective.

Shivnani, Anand M.D. 

Journal of the American Medical Association
Adjuvant chemotherapy with gemcitabine for patients with resectable pancreatic cancer (Letter ot Editor)

Hutson, Thomas E. DO, PharmD, FACP 
B. Escudier, T. Eisen, W.M. Stadler, C. Szczylik, S. Oudard, M. Siebels, S. Negrier, C. Chevreau, E. Solska, A. Desai, F. Rolland, T. Demkow, M. Gore, S Freeman, B Schwartz, M. Shan, R. Simantov, R.M. Bukowski for the Sorafenib TARGETs Clinical Trial Group.

New England Journal of Medicine
Treatment Approaches in Renal cancer Global Evaluation Trial (TARGETs)

Hutson, Thomas E. DO, PharmD, FACP 
RJ Motzer, P Tomczak, MD Michaelson, RM Bukowski, O Rixie, S Oudard, S Negrier, C Szczylik, ST Kim, I Chen, CM Baum and RA Figlin

New England Journal of Medicine
Phase III randomized trial of sunitinib malate versus interferon-alfa as first-line systemic therapy for patients with metastatic renal cell carcinoma.

Shivnani, Anand M.D. 

New England Journal of Medicine
Prophylactic Cranial Irradiation in Extensive Small-Cell Lung Cancer.

Hutson, Thomas E. DO, PharmD, FACP 
BJ Roth

Oncologist
Management of recurrent testicular germ cell tumors.

Hutson, Thomas E. DO, PharmD, FACP 
RA Figlin

Oncology
The evolving role of novel targeted agents in renal cell carcinoma.

Goldman, Stan M.D. 
Rakheja D, Wilson K, Lenarsky C, Weinthal J, Schultz R.

Pediatric and Developmental Pathology
Translocation associated primitive round cell sarcoma: report of a case and review of the literature.

Pippen, John E., JR. MD, F.A.C.P. 
Gong Y, Yan K, et al.

The Lancet
Determination of oestrogen-receptor status and erb b2 status of breast carcinoma: a gene expression profiling study.

Hutson, Thomas E. DO, PharmD, FACP 
E Segota, T Mekhail, T Olencki, R Dreicer, B Wacker, B Osterwalder, P Elson, M Zhou, and RM Bukowski

Urology Oncology
Phase II trial of capecitabine and rHU-interferon-alpha-2a in patients with metastatic renal cell carcinoma, limited efficacy and moderate toxicity.

McCollum, David M.D. 
Bingyan Wu, Jeffrey W. Clark, Matthew H. Kulke, Peter C. Enzinger, David P. Ryan, Craig Earle, Ann Michelini, Charles S. Fuchs, MD, MPH.

American Journal of Clinical Oncology
The Combination of Capecitabine and Thalidomide in Previously Treated, Refractory Metastatic Colorectal Cancer.

Fay, Joseph Wayne, M.D. 
Saracino, G, Agura, E., Berryman, B., Pineiro, L.

American Society of Hematology
Prevention of Graft-Versus-Host Disease (GVHD) with Tacrolimus after Allogeneic Grafting for Hematological Malignancies Following Sub-myeloablative Conditioning.

Hutson, Thomas E. DO, PharmD, FACP 
TK Choueiri, T Mekhail, R Ganapathi, GE Kelly and RM Bukowski

Annals of Oncology
Phase I trial of phenoxodiol delivered by continuous intravenous infusion.
DeZee, Kent J and Shimeall, William T and Douglas, Kevin M and Shumway, Nathan M and O’Malley, Patrick G
Archives of Internal Medicine
Treatment of excessive anticoagulation with phytonadione (vitamin K): a meta-analysis

John Sandbach, M.D.
John Cox, M.D.; Marcus Neubauer, M.D.; Andrew D. McCollum, M.D.; Thomas Cartwright, M.D.; Michael A. Monticelli, M.D.; Kristi A. Boehm, M.S.; Des Ilegbodu, DrPh; Lina Asmar, Ph.D.

ASCO Gastrointestinal Cancers Symposium
A Phase II study of gemcitabine plus zoledronic acid in Stage IV cancer of the pancreas.

Cooper, Barry, M.D. 
Gregory, T.F.

Baylor University Medical Center Proceedings
Case report of an acquired factor XIII inhibitor: diagnosis and management.

Cooper, Barry, M.D. 
Roberts, W.C.

Baylor University Medical Center Proceedings
MD: a conversation with the editor.

Roger M. Lyons
Louis M. Aledort, Gary Okano, Joseph Leveque

Blood
The Clinical and Direct Medical Cost Burden of Splenectomy Among Managed Care Patients with Chronic Immune Thrombocytopenic Purpura (ITP)

Download full publication here.

Roger M. Lyons
Louis M. Aledort, Gary Okano, Joseph Leveque

Blood
Retrospective Matched Cohort Study of Immune Thrombocytopenic Purpura (ITP): Complications Related to Corticosteroid (CS) Use

Download full publication here.

Roger M. Lyons
David Kuter, James Bussel, James George, Louis Aledort, Alan Lichtin, Jorge Nieva, Jeffrey Wasser, Emanuelle Bourgeois, Mies Kappers-Klunne, Francois Lefrere, Martin Schipperus, Reggie Kelly, Jenny Christal, Matthew Guo, Janet Nichol

Blood
Long-term Dosing of AMG 531 in Thrombocytopenic Patients with Immune Thrombocytopenia Purpura: 48-week Update

Download full publication here.

Roger M. Lyons
Hagop M. Kantarjian, Francis Giles, Alan F. List, Sherry Price, Robert Deuson, Joseph Leveque

Blood
The Incidence and Impact of Thrombocytopenia in Myelodysplastic Syndromes (MDS)

Download full publication here.

Roger M. Lyons
Thomas Cosgriff, Sanjiv Modi, Heidi McIntyre, C.L. Beach, Jay T. Backstrom

Blood
Hematologic Improvement, Transfusion Independence, and Safety Assessed Using Three Alternative Dosing Schedules of Azacitidine in Patients with Myelodysplastic Syndromes

Download full publication here.

Roger M. Lyons
Janice Gabrilove, Ronald Paquette, Chaudhry Mushtaq, Mikkael A. Sekeres, Hung Lam, Lyndah Dreiling

Blood
The Efficacy and Safety of Darbopoetin Alfa For Treating Anemia in Low-Risk Myelodysplastic Syndrome Patients: Results After 53-55 Weeks

Download full publication here.

John Sandbach
Frankie Ann Holmes, David Loesch, Sasha Vukelja, Joanne L Blum, Kristi J McIntyre, John E Pippen1, WJ Hyman, Don A Richards, Kristi Boehm, Lina Asmar, Joyce O’Shaughnessy.

Breast Cancer Research and Treatment
Are granulocyte colony-stimulating growth factors (CSF’s) needed to prevent febrile neutropenia (FN) for course #1 of adjuvant chemotherapy with “standard” doxorubicin-cyclophosphamide (ASC) Results from two consecutive US Oncology community adjuvant trials.

Balasubramanian, Lakshmi M.D. 
Bennett CL, Evens AM, Andritsos LA, Mai M, Fisher MJ, Kuzel TM, Angelotta C, McKoy JM, Vose JM, Bierman PJ, Kuter DJ, Trifilio SM, Devine SM, Tallman MS.

British Journal of Haematology
Haematological malignancies developing in previously healthy individuals who received haematopoietic growth factors: report from the Research on Adverse Drug Events and Reports (RADAR) project.

Hellerstedt, Beth M.D. 
Mackler NJ, Dunn RL, Cooney KA, Fardig J, Olson K, Pienta KJ, Smith DC.

Cancer
Dose Escalation of Oral Vinorelbine in Combination with Estramustine in Hormone-Refractory Adenocarcinoma of the Prostate

Hutson, Thomas E. DO, PharmD, FACP 
RJ Halbert, RA Figlin, MB Atkins,  M Bernal, TE Hutson, RG Uzzo, RM Bukowki, KD Khan, RJ Motzer, CG Wood, and  R Dubois

Cancer
Treatment of Patients with Metastatic Renal Cell Carcinoma: A RAND appropriateness panel

Roger M. Lyons, MD
Steven R. Deitcher, MD, Craig M. Kessler, MD, Geno Merli, MD, James R. Rigas, MD, Roger M. Lyons, MD, Jawed Fareed, PhD

Clinical and Applied Thrombosis/Hemostasis
Secondary Prevention of Venous Thromboembolic Events in Patients With Active Cancer: Enoxaparin Alone Versus Initial Enoxaparin Followed by Warfarin for a 180-Day Period

Download full publication here.

Blum, Joanne L. M.D., Ph.D. 
O’Shaughnessy, JA.

Clinical Breast Cancer
Capecitabine/taxane combination therapy: evolving clinical utility in breast cancer.

Pippen, John E., JR. MD, F.A.C.P. 
Dodwell, D.

Clinical Breast Cancer
Time to response: comparison of fulvestrant and oral endocrine agents.

Hutson, Thomas E. DO, PharmD, FACP 
RM Bukowski

Clinical Genitourinary Cancer
A phase II study of GW786034 using a randomized discontinuation design in patients with locally recurrent or metastatic clear-cell renal cell carcinoma.

Hutson, Thomas E. DO, PharmD, FACP 
W Berry

Clinical Genitourinary Cancer
Systemic Chemotherapy for Urothelial Cancer.

Balasubramanian, Lakshmi M.D. 
Evens, AM.

Current Opinions in Oncology
Targeting angiogenesis for the treatment of sarcoma.

Barker Jr., Jerry L., M.D. 
Rosenthal DI, Asper JA, Garden AS, Chao KSC, Morrison WH, Weber RS, Ang KK.

Head Neck
Importance of patient examination to clinical quality assurance in head and neck radiation.

Blum, Joanne L. M.D., Ph.D. 
Dees EC, Chacko A, Loane L, Ethirajan S, Hopkins J, McMahon R, Merten S,  Negron A, Neubauer M, Ilegbodu D, Boehm K, Asmar L, O’Shaughnessy JA.

Journal of Clinical Oncology
Phase II trial of capecitabine and weekly paclitaxel as first-line therapy for metastatic breast cancer.

Blum, Joanne L. M.D., Ph.D. 
Jones SE, Savin MA. Holmes FA, O’Shaughnessy JA, Vukelja S, McIntryre KJ, Pippen JE, Kirby R, Sandbach J, Hyman WJ, Khandelwal P, Negron AG, Richards DA, Anthony SP, Mennel RG, Boehm KA, Mayer WG, and Asmar L,.

Journal of Clinical Oncology
Results of a Phase III trial doxoroubicin/cyclophosphamide (AC) compared to docetaxel/cyclophosphamide (TC) as adjuvant therapy for operable breast cancer.

Fay, Joseph Wayne, M.D. 
Palucka AK, Nemunitis J, Weber J, Ueno H, Auditore-Hargreaves K, Banchereau J

Journal of Clinical Oncology
Vaccination of stage IV melanoma patients with dendritic cells generated ex vivo with type I interferon and loaded with heat-treated killed allogeneic melanoma cells – Preliminary report from the phase II clinical trial.

Hoverman, J. Russell M.D. 
Hansen K, Richardson D, Shuey K.M., Dugger P.C.

Journal of Clinical Oncology
The Development of an Outpatient Chemotherapy Medication Safety Program.

Hutson, Thomas E. DO, PharmD, FACP 
Galsky, and WR Berry

Journal of Clinical Oncology
Problems with randomized discontinuation design.

Roger M. Lyons
Hagop M. Kantarjian, Francis Giles, Alan F. List, Sherry Price, Robert Deuson, Joseph Leveque

Journal of Clinical Oncology
Darbopoetin Alfa for Treating Anemia in Low-Risk Myelodysplastic Syndrome Patients: Interim Results After 27/28 Weeks

Download full publication here.

Roger M. Lyons
J. Gabrilove, R. Paquette, C. Mushtaq, M. Sekeres, H. Lam, L. Dreiling

Journal of Clinical Oncology
Darbepoetin Alfa for Treating Anemia in Patients with Low-Risk Myelodysplastic Syndromes: Exploratory Analysis of Baseline Predictors of Response

Download full publication here.

Roger M. Lyons
S. Anthony, T. Cosgriff, S. Modi

Journal of Clinical Oncology
Transfusion Independence Assessed During Three Alternative Dosing Schedules of Azacitidine in Patients with Myelodysplastic Syndromes

Download full publication here.

Fay, Joseph Wayne, M.D. 
Ueno H, Connolly J, Banchereau J, Palucka AK

Journal of Clinical Oncology
Durable clinical responses in patients with metastatic melanoma vaccinated with dendritic cells loaded with killed allogeneic melanoma cells.

John Sandbach
Stephen E Jones, Michael A. Savin, Frankie Ann Holmes, Joyce A. O’Shaughnessy, Joanne L. Blum, Svetislava Vukelja, Kristi J. McIntyre, John E. Pippen, James H. Bordelon, Robert Kirby, William J. Hyman, Pankaj Khandelwal, Angel G. Negron, Donald A. Richards, Stephen P. Anthony, Robert G. Mennel, Kristi A. Boehm, Walter G. Meyer, Lina Asmar.

Journal of Clinical Oncology
Phase III Trial Comparing Doxorubicin Plus Cyclophosphamide With Docetaxel Plus Cyclophosphamide As Adjuvant Therapy for Operable Breast Cancer. 

Roger M. Lyons, M.D.
James B. Bussel, M.D., David J. Kuter, M.D., D.Phil., James N. George, M.D., Robert McMillan, M.D., Louis M. Aledort, M.D., George T. Conklin, M.D., Alan E. Lichtin, M.D., Jorge Nieva, M.D., Jeffrey S. Wasser, M.D., Israel Wiznitzer, M.D., Reggie Kelly, B.S., Chien-Feng Chen, Ph.D., Janet L. Nichol, M.S.

New England Journal of Medicine
AMG 531, a Thrombopoiesis-Stimulating Protein, for Chronic ITP

Download full publication here.

Shivnani, Anand M.D. 
 Rimel BJ, Schink J, and Small W Jr..

Oncology
Cancer of the Cervix: Current Management and New Approaches.

McCollum, David M.D. 

Proc (Bayl Univ Med Cent)
Stage III colon cancer at Baylor University Medical Center at Dallas and the Baylor Sammons Cancer Center: experience from 2000 to 2004.

Esler, William Vance, M.D. 
Rohrer JE, Saeed Q, Saeed S, Periman P, Beggs D, Hancock P, Lim S.H.

Support Care Center
Risk of mistaken DNR orders.

Hoverman, J. Russell M.D. 
Syrigos KN, Nutting CM, Roussos C, eds.

Tumors of the Chest - Biology, Diagnosis and Management
Financial Aspects of Lung Cancer.
Chawla, Jane S.
UT Southwestern
Acute Intermittent Porphyria

Patt, Debra M.D. 
Giordano, Sharon H.

Women's Health
Paclitaxel in Breast Cancer.
Patt, D, Goodwin J, Kuo, Y, Freeman J, Zhang D, Buccholz T, Hortobagyi G, Giordano S.
Journal of Clinical Oncology
Cardiac morbidity of adjuvant radiotherapy in patients with early stage breast cancer
Patt D, Shopland D, Anderson C, Burns D, Dunnington J, Gritz E.
Texas Medicine
Trends to protect workers from job related secondhand smoke in Texas
Chawla, Jane S.
Washington University in St. Louis
Pharmacogenetics and Chemotherapy
Shumway, Nathan M and Weiss, Brendan M and Ketchum, Lloyd H and Reid, Thomas J
Blood
Hematology Consultation along with the 4 T’s Clinical Scoring System Improves the Evaluation and Management of Heparin Induced Thrombocytopenia.

John Sandbach, M.D.
David Loesch, M.D.; F. Anthony Greco, M.D., Joyce O’Shaughnessy, M.D.; Nicholas Robert, M.D.; Neil N. Senzer, M.D.; Howard A. Burris, M.D.; John D. Hainsworth, M.D.; Sasha Vukelja, M.D.; Frankie Holmes, M.D.; Scot Sedlacek, M.D.; Deborah Lindquist, M.D.; Kristi A. Boehm, M.D.; Feng Zhan, Ph.D.; Lina Asmar, Ph.D.

Breast Cancer Research and Treatment
A randomized, multicenter phase III trial comparing regimens of doxorubicin + cyclophosphamide followed by paclitaxel or doxorubicin + paclitaxel followed by weekly paclitaxel as adjuvant therapy for patients with high risk breast cancer.
Wilson, Ramey L and Eliasson, Arn H and Shumway, Nathan M and Howard, Robin S and Shorr, Andrew F and Parker, Joseph M
CHEST Journal
Treating Air Hunger at End-of-Life
Shumway, Nathan M and Eliasson, Arn H and Wilson, Ramey L and Howard, Robin S and Shorr, Andrew F and Parker, Joseph M
CHEST Journal
Prospective Observation of Air Hunger in Severely Ill Patients
Shumway NM, Kelly WF, Moquin ME, Eliasson AH.
American Thoracic Society ATS
Treatment of air hunger at end of life
Sukin SW, Chhikara, Zhu Z, Ayala G, Kadmon D, Miles BJ, Thompson TC, Aguilar-Cordova E
Molecular Therapy
In vivo surgical resection plus adjuvant gene therapy in the treatment of mammary and prostate cancer
Mutchnik SE, Sukin SW, Boone, TB
Contemporary Urology
Case studies in voiding dysfunction
Ingrams DR, Sukin SW, Ashton P, Valtonen HJ, Pankratov MM, Shapshay SM
Otolaryngology-Head and Neck Surgery
Does slow release of 5-fluorouracil and triamcinolone reduce subglottic stenosis?